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Jose Fabian Victorino 
SSU72 AND RTR1 SERINE 5 PHOSPHATASES AND THEIR ROLE IN NNS AND 
CPF TRANSCRIPTION TERMINATION 
Polyadenylation dependent transcription termination is dependent on the Cleavage 
and Polyadenylation Factor complex (CPF) which is essential for the termination and 
processing of mature RNA. Polyadenylation (PolyA) independent transcription 
termination is carried out by the NNS (Nrd1-Nab3-Sen1) termination pathway, which 
helps regulate termination and processing of non-coding RNA (ncRNA). The disruption 
of these pathways can impact expression of nearby genes, both protein coding and non-
coding. Recruitment of termination pathway components is achieved through a domain 
unique to the largest subunit of RNA Polymerase II (RNAPII) referred to as the C-
terminal domain (CTD), which contains a repeating heptad sequence, Y1S2P3T4S5P6S7, 
and acts as a docking site for transcription regulatory proteins. Ssu72 is a serine 5 
phosphatase and an essential member of the CPF complex. Rtr1 is also a serine 5 
phosphatase, but its mechanism of action is less well characterized. Both Rtr1 and Ssu72 
regulate transcription machinery recruitment through control of the phosphorylation 
status of the CTD. My studies have focused on Rtr1 and Ssu72 mutants in yeast which 
show evidence of transcription termination related phenotypes. Chromatin 
immunoprecipitation of RNAPII followed by exonuclease treatment (ChIP-exo) studies 
provide evidence of RNAPII transcription continuing through termination sites at ncRNA 
genes as a result of a hyperactive Ssu72-L84F mutant, while an RTR1 knockout results in 
increased premature RNAPII transcription termination. Northern blots and RNA 
sequencing confirm premature transcription termination and decreased total RNA 
vii 
expression in the RTR1 knockout and increased length of ncRNA transcripts as well as 
total RNA expression in the Ssu72-L84F mutant. Mass spectrometry analysis has 
identified changes in the protein-protein interactions (PPI) within the CPF complex in the 
Ssu72-L84F mutant and decreased PPIs between different transcription machinery in 
RTR1 knockout cells. My results show that the CTD phosphatases Rtr1 and Ssu72 play 
unique roles in the regulation of RNAPII termination in eukaryotes.  
 
 
Amber Mosley Ph.D., Chair 
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RNA Transcription  
The process of transcription is highly regulated in order to achieve proper 
differential gene expression, and yet full understanding of the mechanisms involved in its 
initiation, elongation, and termination are still lacking. With the advent of new 
technology and techniques, gains have been made in understanding transcription and 
discovering more direct relationships between the transcriptional machinery and human 
disease. Proteins involved in transcription have been linked to a wide range of diseases, 
such as human immunodeficiency virus (HIV), neurodegenerative ataxias, ataxia with 
oculomotor apraxia type 2 (AOA2), and myofibrillar myopathies [1-7]. Many cancers 
have been discovered to be “transcription addicted” meaning that they require the 
upregulation of transcriptional machinery in order to proliferate [8]. These observations 
underscore the need for high levels of regulation during transcription, and that all players 
in the process of transcription are very important to achieve a working system that can 
receive nuclear, cellular, and environmental signals to regulate appropriate expression of 
RNA. 
 
1. RNA Polymerases 
In eukaryotes there are five RNA Polymerases (RNAPI-V), each polymerase with 
a specialized role in the production of specific subclasses of RNA. RNAPIV and RNAPV 
are only found in plants and will not be discussed at length here. RNAPI, RNAPII, and 
RNAPIII have a conserved catalytic core of 10 proteins Rpb5, Rpb6, Rpb8, Rpb10, 
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Rpb12 and five other subunits that are encoded by different genes depending on the 
which polymerase (RNAPI/RNAPII/RNAPIII) they are a part of; A190/Rpb1/C160,  
A135/Rpb2/C128, AC40/Rpb3/AC40, AC19/Rpb11/AC19 and A12.2(N 
ribbon)/Rpb9/C11(N ribbon) [9]. The three polymerases also have homologous 
heterodimeric subcomplexes A14/43, Rpb4/7, and C37/53 that form a stalk for RNAPI, 
RNAPII, and RNAPIII respectively [10]. RNAPI transcribes the ribosomal 18S, 5.8S, 
and 28S RNA (rRNA) which represents ~80% of the total RNA produced in a yeast cell 
[11].  RNAPI contains 14 subunits, there are two proteins in this complex that are not 
homologous to RNAPII being A49 (N-terminal domain) and A34.5 that have homology 
to subunits of transcription initiation factor F (TFIIF) [10]. RNAPIII synthesizes transfer 
RNA (tRNA) and 5S rRNA that account for 15% of total RNA [11]. RNAPIII contains 
17 subunits; the additional proteins that are not homologous to RNAPII are C37, C53, 
C82, C34, and C31 [10]. 
RNA polymerase II (RNAPII) transcribes messenger RNA (mRNA) as well as a 
diverse set of other transcripts including: microRNA (miRNA), long non-coding RNA 
(lncRNA), small nuclear RNA (snRNA), small nucleolar RNA (snoRNA), and other non-
coding RNA (ncRNA) (Figure 1) [12, 13]. RNAPII is thought to be responsible for 
cellular differentiation as well as to maintain the identity of a cell when responding to 




Figure 1: RNA Polymerase II complex. Artistic rendering of a structure of a paused 
RNAPII complex (PDB ID: 3HOU) [14]. RNA is in red; DNA strands are in purple and 
light blue. The CTD is truncated at the linker region before heptad repeats begin. Serine 5 


















RNAPII is a 12-subunit complex with a catalytic core of ten proteins (Rpb1-3, 5,6,8-12) 
and two dissociable subunits Rpb4 and Rpb7 that appear to be most associated with the 
RNAPII core during initiation with interactions decreasing during continuing elongation. 
[15, 16]. Rpb1 is the largest of the core proteins at ~220kDa and contains a regulatory 
domain, called the C-terminal domain (CTD) with a sequence of heptad amino acid 
repeats (YSPTSPS), which directs the different stages of transcription from initiation to 
elongation [17]. The other RNAPII subunits have several functions which help grip 
DNA/RNA and form different channels for these molecules to enter and exit as well as 
aid in the production of RNA. Additionally, RNAPII interacts with other transcription 
regulatory proteins during initiation, elongation and termination for proper RNA 
formation and processing.  
 
2. RNAPII Initiation 
A great deal of work has been focused on RNA Polymerase II (RNAPII) 
transcription initiation which has led to the discovery of many proteins involved in 
transcription that stabilize and localize RNAPII at promoter regions to help in the 
initiation of RNAPII at protein coding genes specifically at transcription start sites (TSS) 
[18]. During initiation, general transcription factors TFIIB (Sua7), TFIID, TFIIE, TFIIF, 
TFIIH are recruited to the DNA promoter to form a pre-initiation complex (PIC). The 
initial step of forming the classical PIC is the binding of the TATA-box binding protein 
(TBP) to the consensus sequence TATAWAWR ~30 bp upstream of the TSS, which 
bends the DNA to prepare it for initiation [19]. A large percentage of promoters do not 
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contain TATA box sequences 80-90%; however, TBP is still present in these regions 
along with 13-14 TAF proteins, which help in identifying other promoter sequences, and 
together form the TFIID complex [20-22]. TFIID is conserved from yeast to humans and 
is involved in the recognition of core promoter sequences. TFIIA consists of proteins 
Toa1 and Toa2 and although not required for basal transcription it helps to stabilize the 
TFIID/DNA complex [23]. TFIIB (Sua7) is required for the recruitment of RNAPII 
through TFIIBs N-terminal domain and also helps stabilize the TFIID-DNA complex, 
through the TFIIDs C-terminal domain, and helps the promoter DNA open for the 
loading of RNAPII [23-26]. TFIIF (Tfg1/2/Taf14) is thought to stabilize and add 
specificity of RNAPII to its interaction with DNA [27]. TFIIE (Tfa1/2) binds to RNAPII 
and is required for the DNA to open at the promoter and also facilitates the recruitment of 
TFIIH [28-30]. The TFIIH complex is composed of a 7-subunit core, with helicase 
activity, and a 3-subunit protein kinase module, which includes kin28 and is responsible 
for phosphorylating serine 5 and serine 7 of the RNAPII CTD [28, 31-36]. This complex 
is essential for in vivo initiation and transcription and promotes processive transcription 
in a variety of ways including its DNA dependent ATPase activity, promoter opening and 
escape, and nucleotide excision and repair [37-41]. 
In addition to the primary pre-initiation complex (PIC) components, there are 
several other protein complexes and mechanisms that impact initiation and sometimes are 
involved in elongation and/or termination. The first of these is the nucleosome that is 
composed of a core of four proteins called H2A, H2B, H3 with H4 and 147 nucleotides 
of DNA wrapped around the core, which acts as a roadblock for transcription to occur 
[42-44]. In order for the nucleosomes to be assembled and disassembled at the 
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appropriate locations, several proteins have to interact with the histones. These include 
chromatin remodelers, histone chaperones, and histone variant readers which sometimes 
interact with histone tails, often removing or adding post translational modifications 
(PTMs) to induce a conformational change leaving regions of DNA open for other 
transcription factor proteins to bind to the DNA in a nucleosome free regions (NFR) [45-
47]. NFRs are often found at promoters and enhancer regions of genes and are necessary 
for consistent RNA production from those particular genes [48]. These NFRs often allow 
several different transcription factor proteins to bind to the same region of DNA. These 
proteins can then also interact with other regulatory proteins that help activate 
transcription. One such complex of regulatory proteins called the Mediator is thought to 
bind to and activate several DNA sequence-specific transcription factors (TFs), possibly 
at the same time to facilitate initiation.  
The Mediator complex is made up of a core of 26 proteins and the four subunit 
cyclin dependent kinase module called cyclin dependent kinase 8 (CDK8) module 
(CDK8, CCNC, MED12, MED13) [49]. Mediator is necessary for the formation of the 
PIC through the many contacts it has with RNAPII and helps recruit TFIIH, but is also 
involved in mediating several other TFs [50]. The catalytic subunit of TFIIH (Kin28) 
phosphorylates serine 5 of the CTD and results in the eviction of Mediator from RNAPII 
and thus initiation of transcription [51, 52]. Mediator is also directly involved with 
RNAPII and has been shown to bind to the CTD, but without the CDK8 module; 
mediator is thought to have two conformations, a core only mediator complex and a 
CDK8 module plus core complex. The CDK8 module together with core Mediator helps 
recruit the super elongation complex (SEC) which phosphorylates serine 2 on the CTD 
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via the CDK9 (Bur1) kinase [53-59]. These finding clearly established that the Mediator 
can act on transcription at initiation as well as during elongation. 
 
3. RNAPII Elongation 
Transcription elongation is a highly regulated phase of the transcription cycle that 
has become better understood in the last decade. In metazoans, transcription has been 
shown to pause at a significant number of RNAPII target genes soon after initiation at 20-
120 nucleotides downstream of the TSS [60]. Pausing has been shown to occur through 
the action of the two complexes DSIF and NELF [61]. NELF is a complex only found in 
metazoans and is made up of 4 subunits: the core NELF-A and NELF-C which associates 
with NELF-B and NELF-D [62]. All four subunits of NELF have the capability to 
interact with RNA which could be part of a possible mechanism for pausing [62, 63]. 
NELF also appears to stabilize a paused RNAPII and inhibits premature termination [64, 
65]. DSIF is composed of two proteins Spt4 and Spt5, which are conserved from yeast to 
humans. There is an Spt5 homolog in bacteria NusG [66-68]. Spt5 has a CTD domain 
which can be phosphorylated by TFIIH, as well as P-TEFb, and likely pauses RNAPII by 
interactions with nascent RNA at the exit channel of RNAPII [69-71]. Spt5 is also 
involved in the recruitment of the capping complex together with the phosphorylation of 
serine 5 on the CTD [72].  
Messenger RNA processing mostly occurs co-transcriptionally, and begins as 
soon as the 5’ end of the transcript emerges from the RNAPII exit channel (Figure 2) 
[73]. The 7-methyl guanosine cap is added, which is important for stability of the RNA 
and also helps during RNA export [73-75].   
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Figure 2: Overview of the different stages of transcription. A simplistic preview of the 
different stages of transcription are depicted. Blurry RNAPII complexes are meant to 
simulate an actively elongating process. Other RNAPII complexes depict a paused or 
stopped polymerase[76]. 
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Capping is carried out by three enzymes in yeast, Cet1 which hydrolyzes the gamma 
phosphate of 5’ RNA triphosphate, Ceg1 which adds guanosine monophosphate to the 
RNA diphosphate end and Abd1 which methylates the terminal guanine [77-80]. 
 In mammalian cells, capping enzyme (gene name RNGTT) is bifunctional with both the 
5’ triphosphatase activity and mRNA guanylyltransferase activity encoded in a single 
protein [81-83]). In addition, a cap binding complex (CBC) which consists of Cbc2 and 
Sto1 in yeast, binds to the mRNA cap to further stabilize the RNA and perhaps provides 
feedback to stimulate transcription elongation [84, 85]. Co-transcriptional processing can 
also serve to signal for the decay of the nascent RNA such as when mRNA is not 
properly capped [86, 87]. Splicing can also occur co-transcriptionally, though not 
exclusively. It is possible that most spliceosomes (a large complex composed of 
approximately 80 proteins that is responsible for splicing introns from the premature 
mRNA), assemble on the nascent RNA transcript [88, 89]. 
Another interesting elongation complex, polymerase-associated factor 1 (Paf1C) 
(Cdc73, Ctr9, Leo1, Paf1 and Rtf1), is involved in multiple stages of transcription. Paf1C 
inhibits release of a paused RNAPII, but once released Paf1C positively regulates 
elongation of RNAPII [90, 91]. In addition, the Rtf1 subunit of Paf1C promotes the 
monoubiquitylation of H2B which influences chromatin structure during transcription 
[92]. Finally, to release the paused RNAPII, the positive transcription elongation factor 
complex (P-TEFb) phosphorylates serine 2 of the CTD, the CTD of Spt5, and the NELF 
complex [60, 93]. P-TEFb is a kinase complex consisting of CDK9 (Bur1) and cyclin T, 
and is a constituent of 3 bigger complexes including the SEC complex and is better 
known for the kinase activity of subunit Bur1. Once phosphorylated, NELF dissociates 
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from chromatin while a phosphorylated DSIF turns into a positive regulator of 
transcription elongation [94-96]. To continue elongation, nucleosomes must be removed 
from the chromatin downstream of RNAPII, and one of the complexes involved is the 
facilitates chromatin transcription complex (FACT).  FACT (Spt16/Pob3) interacts 
directly with the H2A-H2B dimer to disassemble it from the DNA, allowing RNAPII to 
continue elongation [97, 98]. Other nucleosome interacting proteins/complexes such as 
Spt6, Chd1, COMPASS complex, Set2D, Bre1-Rad6, Dot1, and ISWI complex also take 
part in modifying the nucleosome for the progression of RNAPII [99-104]. 
 
4. RNAPII Termination 
While initiation and elongation are critical, termination is likewise important for 
the proper RNA species to be stabilized and translated into protein. Variations in the end 
final stages of RNA production could cause major alterations in the mRNA 3’ end 
stability and/or the turnover and recycling of RNAPII and therefore be disastrous for the 
cell. In order for transcription termination to occur at the appropriate location the RNA 
must be cleaved at the appropriate location, and then must be properly polyadenylated to 
avoid inappropriate mRNA degradation either within or outside of the nucleus of the cell 
and, in the case of mRNA, eventually be translated to the correct protein sequence. 
Currently there are well-described working models of eukaryotic transcription 
termination. One of these is the poly-A-dependent termination pathway which relies on 
the cleavage and polyadenylation factor complex and the cleavage factor complex (CPF-
CF) termination factor. The CF complex consist of two sub-complexes CFIA (Pcf11, 
Rna14, Rna15, and Clp1) and CFIB (Hrp1). Hrp1, also known as Nab4, is required for 
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pre-mRNA cleavage and binding upstream of the UAUAUA sequence [105]. The CFIA 
complex is required for mRNA cleavage but also has a role in interacting with serine 2 of 
the CTD through the protein Pcf11 [106-109]. Additionally, CFIA may have a role in 3’ 
end processing of small nucleolar RNA, snoRNA, which is required for guiding chemical 
modifications of other RNAs [106-109]. The CPF complex consists of 15 proteins Cft2, 
Mpe1, Ysh1, Glc7, Pta1, Pti1, Ref2, Ssu72, Swd2, Syc1 Cft1, Fip1, Pap1, Pfs2, and 
Yth1. The CPF complex contains the two major enzymes that perform the cleavage, 
Ysh1, and polyadenylation, Pap1. The other subunits likely have a variety of mechanistic 
roles but are also known to help stabilize and localize the position of the RNA of pre-
mRNA cleavage [110, 111]. In vitro, the three budding yeast complexes CFIA, CFIB and 
CPF are sufficient to complete the process of cleavage and polyadenylation of pre-mRNA 
in budding yeast [112, 113]. Following polyadenylation, the mRNA is bound by poly(A) 
binding protein Pab1 and Nab2 which together stabilize the mRNA and guide its export 
out of the nucleus along with the cap binding complex described earlier [114, 115].  
Transcription termination also requires that RNAPII be removed from the single 
stranded DNA template for which two models of the mechanism of action have been 
proposed. The first is the allosteric model that suggests that there is a conformational 
change that occurs after elongation factors dissociate from RNAPII to facilitate template 
release. The other is the “torpedo model” which involves a more direct approach. Rat1, a 
5’-3’exonuclease, would degrade the remaining nascent RNA that remains on the 
RNAPII dislodging it from the template DNA strand with the help of its interacting 
partner Rai1, a decapping endonuclease, and a CTD interacting protein Rtt103 [116-120]. 
While Rat1 and Rai1 are involved in the termination mechanism, they are also involved 
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in the general degradation of unstable RNA [121-124]. Additionally, there is a distinct 
RNA quality control mechanism that is active in the cytoplasm and also involves an RNA 
decapping complex (Dcp1 and Dcp2) as well as another 5’-3’ exonuclease Xrn1 [125-
127]. There is also a major complex that degrades improperly processed pre-mRNA or 
unstable RNA in the nucleus and in the cytoplasm called the exosome [128-132]. The 
exosome is composed of a core of nine proteins in a stacked ring conformation. The 
bottom ring of the core contains Rrp41, Rrp42, Rrp43, Rrp45, Rrp46 and Mtr3 while the 
top ring has Rrp4, Rrp40 and Csl4 [133]. The exosome curiously has two 3’-5’ 
exonuclease enzymes Dis3 and a nucleus specific Rrp6 [134]. 
Another termination mechanism is called the poly-A-independent termination 
pathway or the NNS termination pathway, which is so named after three proteins, Nrd1, 
Nab3 and Sen1. Nrd1 has a CTD interaction domain which binds to a phosphorylated 
serine 5 CTD during early elongation and has an RNA recognition motif as well as a 
Nab3 interaction domain [135-137]. Nab3 also has an RNA recognition motif and an 
Nrd1 interacting domain and forms a heterodimer with Nrd1 [138-140]. Sen1 is an ATP 
dependent RNA-DNA helicase that is thought to stimulate termination by disturbing the 
transcription elongation complex [137, 141-146]. This pathway is thought to mainly 
affect ncRNA but appears also to affect mRNA [147-149]. It has been suggested that 
NNS termination is not RNA-type dependent but length-of-transcript dependent, often 
occurring around 90-450 nt after the start of transcription [150, 151]. NNS termination is 
coupled to the processing and degradation of RNA transcripts via Nrd1 and its 
recruitment of the Trf4/5, Air1/2 and Mtr4 polyadenylation complex (TRAMP) and the 
nuclear exosome [12, 152, 153]. Trf4/5 are poly-A polymerases which add a short 
13 
adenine tail at the 3’ end of RNA after NNS termination. Mtr4 is a helicase and can also 
help in managing the size of the adenine tail [154]. The nuclear exosome then either trims 
the adenine tail or completely degrades the RNA depending on the type of transcript and 
other factors [155] 
 
5. Pervasive Transcription 
It is important to understand all steps of transcription including some that might 
not occur in the standard cycle of transcription. Recent work has shown that many 
regions of DNA previously thought to be transcription inactive are undergoing what has 
been called “pervasive transcription” [12, 156-158]. One study found evidence that 85% 
of the genome in yeast is being transcribed [156]. In addition, there is evidence that a 
major source of pervasive transcription occurs at bi-directional promoters and at NFRs, 
resulting in a plethora of ncRNAs such as: stable unannotated transcripts (SUTs), cryptic 
unstable transcripts (CUTs) [12, 13, 159, 160]. The function or purpose of many of these 
emerging ncRNA classes in the nucleus has yet to be completely understood. Nonetheless 
it is known that the production of ncRNA transcripts is dependent on a number of 
different core components of the basal transcription machinery [34, 135, 137, 161-164].  
 
Transcription Elongation and the C-terminal Domain  
The process of RNAPII transcription occurs through different mechanisms, that 
are known to be coupled to RNA processing, which are regulated through the recruitment 
of proteins to the C-terminal domain (CTD) of the largest subunit of RNAPII, Rpb1[34, 
137, 149, 161-164]. 
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1. The Structure of the C-Terminal Domain of Rpb1  
Rpb1 subunit of RNAPII contains the CTD, which is made up of recurring heptad 
amino acid repeats, YSPTSPS, which, when phosphorylated in various patterns, recruits 
different transcriptional proteins (Figure 1) [34, 135, 137, 161-165]. Of the seven amino 
acids, five residues can be phosphorylated and the phosphorylated forms will be referred 
to by as follows: tyrosine-1 (Y1P) serine-2 (S2P) threonine-4 (T4P) serine-5 (S5P) and 
serine-7 (S7P). At any time during transcription, different patterns of amino acid 
phosphorylation likely occur, but the precise combinations at any given point in 
transcription across all heptad repeats is not known. Of the seven residues in each heptad, 
serine 5 and serine 2 were found to be the most extensively phosphorylated in mass 
spectrometry experiments and in vitro studies [166-169]. In addition, the two prolines can 
undergo cis-trans isomerization. The modifications of all seven amino acids gives the 
CTD a variety of distinct surfaces for different proteins to bind [170]. The CTD is 
conserved across eukaryotes, but different organisms contain a different number of the 
repeating heptads. Humans and most vertebrates have 52 repeats, while Drosophila has 
44, Arabidopsis has 40 repeats and Saccharomyces cerevisiae 26 heptad repeats. The 
CTD is essential and in S. cerevisiae at least 8 heptad repeats are required for viability 
and any Y1P/S2P/S5P substitutions are lethal [163]. There is amino acid sequence 
variation among the repeats with the majority of the variation occurring on the 7th amino 
acid possibly allowing for the different heptads to have regional specificity to certain 
proteins [170]. Whether or not only one heptad is necessary to for all CTD interacting 
proteins is still up to debated. However, one study discovered that any addition of an 
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alanine residue between any heptad in the CTD was lethal in yeast, but up to five 
additional alanine residues could be added in between 2 heptads and still be viable [171].  
As noted, isomerization of prolines 3 and 6 can also affect the structure state of 
the CTD. Proline isomerization is carried out by peptidyl-prolyl cis/trans-isomerases 
(PPIases) [172]. In yeast, this isomerization is carried out by Ess1 which recognizes the 
motif of a phosphorylated Ser5-Pro6 [173]. The proline-6 then goes from a Cis 
conformation to a trans conformation that makes the CTD more energetically favorable 
for certain proteins to bind to therefore adding one more dimension of complexity and 
specificity to the CTD [174, 175]. 
The CTD appears to have a residual secondary structure and it has β-turn 
composition when bound to other proteins, but it is generally flexible and contains a 
linker region that connects the heptads to the rest of Rpb1 [176, 177]. Previous studies 
have focused on the incomplete CTD by using short heptad repeats, and there is still a 
lack of information of the complete CTD’s true structure in vivo. In these shortened 
CTDs, phosphorylation gives the CTD additional hydrogen bonds that appear to 
contribute to β-turn structures in a protein bound CTD. In full length CTD Sucrose 
gradient ultracentrifugation studies phosphorylation suggested an extended CTD 
conformation which may be essential for CTD protein interactions [178]. More recently, 
another group has found expansion of the overall volume of the CTD after 
phosphorylation but also found a reduction in flexibility as well as structural 
heterogeneity throughout the CTD using Small Angle X-ray experiments (SAXS) 
experiments [179]. These data provide further evidence that different sections of the CTD 
may be influencing transcription in different ways. 
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2. Phosphorylation Patterns of the C-Terminal Domain of Rpb1  
Phosphorylation patterns of the CTD are indicators of the relative stage of 
RNAPII during transcription from initiation to termination [34, 162, 164, 180, 181]. 
Although the CTD is required for viability in cells, the CTD is not necessary for the 
catalytic activity of RNAPII [182]. This provides evidence that the CTD is not necessary 
for the synthesis of RNA but for the regulation of the process of transcription. By using 
phospho site specific antibodies, a number of research groups have mapped the relative 
abundance of phosphorylation of each phosphorylated residue group across the 
transcription cycle using chromatin immunoprecipitation based approaches (Figure 3) 
[35, 164, 180, 183-185]. Tyrosine 1 is essential for the viability of a S. cerevisiae cell as 
the substitution of Tyrosine 1 with a phenylalanine is lethal [163].  
Generally, Tyrosine 1 is phosphorylated during early elongation by c-Abl in 
humans and then is dephosphorylated by Glc7 near the termination site; phosphorylation 
is present on RNAPII located at most active genes [151, 186, 187]. Fluorescence 
anisotropy experiments by Mayer et al. showed that Tyrosine 1 phosphorylation leads to 
a decreased ability of CTD peptides to bind to recombinant proteins Pcf11, Nrd1 and 
Rtt103, the only known proteins with CTD interaction domains (CID), which are 
involved in different mechanisms of termination [151]. Y1P; however, appears to 
increase CTD peptide binding to Spt6, an elongation protein that binds a S2P CTD 
through its Src homology domain (SH2) [188].  
Serine 2 is phosphorylated in S. cerevisiae by Bur1 and Ctk1 during early 
elongation and gets dephosphorylated by the Fcp1 phosphatase before the next round of 
transcription [189, 190]. S2P is essential and aligns with periods of elongation, splicing, 
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termination, mRNA processing and export [118, 174, 191-197]. There are two known 
termination factor proteins, Pcf11 and Rtt103, that have a CID specific for a S2P CTD 
[118, 174]. 
Threonine 4 is phosphorylated during mid-stage elongation and is 
dephosphorylated right before the polyadenylation site is reached [151]. Currently there 
is no known threonine 4 kinase in yeast, but in human cells Plk3 has been shown to 
phosphorylate threonine 4 [198]. While T4P is not essential for viability in yeast, it is 
essential in chicken and human cells [171, 199, 200]. The mutation of threonine to valine 
leads to decreased processing of non-polyadenylated histone mRNA as well as defects in 
elongation [198, 200].  
Serine 5 of the CTD heptad is essential and is the most phosphorylated residue. 
Serine 5 is phosphorylated early in transcription and is dephosphorylated as RNAPII 
nears termination [151, 166, 181]. Serine 5 is phosphorylated by Kin28 a subunit of 
TFIIH in S. cerevisiae, and dephosphorylated by both Rtr1 and Ssu72  [34, 201-207]. 
Serine 5 phosphorylation is associated with initiation, the dissociation of the mediator 
complex, promoter release, mRNA capping and early transcription termination via Nrd1 
[83, 135, 136, 208-211].  
Serine 7 begins to be phosphorylated at the beginning transcription and 
phosphorylation levels stay relatively constant throughout the gene in transcription 
process [183, 212-214]. The removal of S7P is lethal in human cells but is not essential in 
yeast and a serine 7 to alanine mutation had no effect on mRNA but affects the correct 
processing of snRNA [33, 199, 215]. Serine 7 is phosphorylated by Kin28 during the 
initiation stage and chemical inhibition studies show that serine 7 stays phosphorylated 
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via Bur1 during the later stages of transcription [34-36, 204, 212]. Ssu72 phosphatase 
removes the serine 7 phosphate immediately after cleavage and polyadenylation [13, 184, 
185, 201, 216, 217]. 
 
3. Transcription Elongation and the CTD 
 Like all stages of transcription, elongation is heavily regulated by the state of the 
CTD. RNAPII release from the promoter is facilitated by phosphorylation of Serine-5 of 
the CTD by Kin28 thus allowing RNAPII to transcribe through the gene. However, 
various other proteins are necessary to maintain RNAPII activity. Often RNAPII stalls or 
pauses during its activity, and phosphorylating the CTD can help RNAPII to begin to 
transcribe again. The structure of a paused mammalian RNAPII elongating complex 
shows that DSIF forms a clamp around upstream DNA and nascent RNA while NELF 
binds the polymerase funnel and opens the trigger loop that inhibits the binding of the 
next nucleotide triphosphate (NTP) [39, 61, 104, 218-220].  
P-TEFb contains a CTD kinase Bur1 which phosphorylates Ser-2 of the CTD and 
also phosphorylates Spt5, NELF, Paf1C, Spt6 and the CTD linker which leads to the 
resumption of RNAPII transcription [94-96, 221, 222]. A recent cryo-EM study showed 
that P-TEFb activity facilitates the formation of a stable complex between RNAPII, 
DSIF, Paf1C, and Spt6 in vitro which may explain the mechanism of unpausing RNAPII 
[104]. Additionally, Vos et al. show that the interaction between Paf1C and Spt6 may 
induce a conformational change releasing the DSIF clamp and promote the rewinding of 
DNA at the transcription bubble promoting elongation [104, 223].   
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Figure 3: Phosphorylation pattern throughout transcription. Phosphorylation for each 
individual acid is mapped based on prevalence. The darker the color, the greater the 
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This is consistent with previous studies showing that Spt6, which binds to S2P of the 
CTD, stimulates elongation in vivo and in vitro [224-227]. In addition, the tandem SH2 
domain of Spt6 appears to bind to a doubly phosphorylated region in the linker of the 
CTD at a phosphorylated Serine (S1493) and at either threonine (T1471) or tyrosine 
(Y1473), which may be phosphorylated by P-TEFb (Ctk1 and or Bur1), that helps 
maintain repressive chromatin thus promoting elongation [104, 228].  
 Paf1C is also implicated in pause release and elongation through its interaction 
with Spt4/5 and the recruitment and activation of histone modifier FACT complex [90, 
91, 224, 229]. The Cdc73 subunit of Paf1C interacts directly with a diphosphorylated 
(S2/S5 and S5/S7) RNAPII CTD through its Cdc73’s own C-terminal domain in vivo and 
helps recruit Paf1C to RNAPII [230-233]. In addition to Rtf1’s role in chromatin 
structure, it also interacts with Spt5, and phosphorylation of the CTD as well as Spt5’s C-
terminal repeats (CTRs) phosphorylation are required for proper recruitment of Paf1C 
[234, 235]. Another study showed that there is a mutual dependence on P-TEFb and 
Paf1C for their own recruitment to active chromatin in a positive feedback mechanism 
that promotes RNAPII pause release by regulating the association of P-TEFb on 
chromatin directly as well as through histone modifications via Paf1C [229, 236]. 
  
Transcription Termination 
 Transcription termination is an important regulator of the expression of non-
coding and coding RNA transcripts [142, 148, 237-242]. Depending on the pathway, 
different RNA transcripts can be degraded, stabilized, or exported to the cytoplasm for 
translation [147, 148, 237]. Currently, there are two model types of RNAPII termination: 
poly-A dependent termination and NNS termination have been proposed (Figure 4).  
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1. Poly-A Independent Termination (NNS Termination)  
Nrd1 has been shown to interact with the nuclear exosome enhancing the ability of the 
exosome, possibly by recruiting the exosome to the site of termination, to degrade RNA 
transcripts in vivo [155]. Interestingly the majority of small ncRNAs are terminated 
during early elongation when serine 5 phosphorylation is most abundant on the CTD, 
[135].  
Nrd1 also interacts directly with the TRAMP complex, which polyadenylates 
RNA transcripts, through poly(A) polymerase proteins Trf4/5 [12, 152, 155]. The 
TRAMP enhances the ability of the exosome to degrade aberrant RNA in vitro [152]. 
Further studies have shown that the TRAMP complex increases the activity of Rrp6 
independent of the exosome [243]. These studies provide evidence that the NNS pathway 
is involved in termination, trimming and degradation of short non-coding RNA 
transcripts with unstable RNA usually being completely degraded. A faulty exosome or 
deficient NNS termination can lead to over-abundance of ncRNA or RNAPII termination 
failure that creates issues downstream such as the suppression of nearby genes, also 
known as transcription interference ([237, 244-249]. Most small ncRNAs, including 
sno/snRNAs, are terminated via the NNS termination pathway in S. cerevisiae which 
generally leads to non-coding transcripts being either degraded or processed [12, 130, 
137, 147, 148, 159, 165, 237, 244, 250]. A number of additional protein complexes 
regulate this process including the TRAMP (Trf4/5– Air2/1– Mtr4 polyadenylation) 
complex and the nuclear exosome that work together to process and polyadenylate small 
functional ncRNAs, such as snRNA and snoRNA [138, 142, 147, 155, 165, 251, 252]. 
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Figure 4: Models of RNA Cleavage-Independent/Dependent Transcription Termination. 
(A) In yeast, the RNA cleavage-independent pathway is also known as the NNS pathway. 
Nrd1 binds to a serine 5 phosphorylated CTD and Nrd1 and Nab3 bind to RNA. Sen1 is a 
DNA/RNA helicase. The TRAMP complex polyadenylates the 3’end of RNA, and the 
exosome (green) processes or degrades RNA. (B) In the Poly-A dependent pathway, 
CF1A is recruited to Ser2 phosphorylated CTD. CPF is recruited and cleaves RNA at the 
polyadenylation signal. Poly(A) polymerase polyadenylates 3’ end of RNA following 
cleavage. Xrn2 degrades the 5’ end of uncapped RNA stimulating RNAPII removal from 
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The exosome is responsible for degrading nonfunctional small ncRNA such as CUTs, 
which generally terminate at about 450 nucleotides after the transcription start site (Table 
1, [12, 148, 150]). SUTs are stable RNA transcripts which are transcribed from regions of 
the genome which were previously unannotated (Table 1, [159]). CUTs were first 
detected in microarray experiments after inhibiting the NNS-coupled degradation 
pathway in a S. cerevisiae strain through the deletion of one of the nuclear exosome 3’-5’ 
exonuclease subunits, RRP6 [12].  
 Gene expression is regulated by early termination at specific RNAPII target 
genes, which has been termed transcription attenuation [142, 237-242, 246, 253, 254]. 
Transcription attenuation of mRNA often occurs at genes which exhibit antisense 
transcription at protein coding genes [237, 246, 254]. Antisense transcripts (ASTs) are 
transcripts of RNA that are produced from the non-coding strand of a protein coding 
gene. Another study discovered that while 80% of S. cerevisiae open reading frames 
(ORFs) had an RNA transcript antisense to the ORF, 30% of ORFs in human liver cells 
had RNA antisense to the ORF [255]. Several studies have classified different categories 
of transcripts and have described their mechanisms of termination and degradation 
(outlined in Table 1). Altering the function of proteins involved in NNS termination has 
led to the discovery of hundreds of ncRNAs, resulting in global changes in the 
transcriptome [12, 13, 130, 159, 160]. Termination is less recognized in the field of 
transcription as a form of regulation of RNA expression than other stages of transcription, 
such as initiation; however, these and other studies suggest that the termination 
machinery plays a major regulatory role in the control of gene expression. 
 
24 
2. Poly-A Dependent Termination (CPF-CF Termination)  
The polyadenylation dependent transcription termination pathway is dependent on 
the CPF and the CFIA/B complexes for the termination and processing of mRNA [112, 
117, 118, 237, 256-260]. Few details of the exact mechanism of transcription termination 
are known  is still unknown. Many proteins involved recognize termination signals and 
cross-talk through mechanisms such as CTD phosphorylation. For example, Glc7, of the 
CPF, is required for the dephosphorylation of tyrosine 1 of the CTD near the AAUAA 
poly(A) termination site. This may help recruit the CF1A subunit Pcf11, and Rtt103 since 
it is thought that tyrosine 1 phosphorylation inhibits the ability of these proteins to bind to 
serine 2 [151, 261]. Pcf11 contains a CTD interaction domain (CID) that is specific to a 
serine 2 phosphorylated CTD at the 3’ end of protein coding genes during transcription 
termination [109, 118, 174, 180, 181, 183]. Rtt103 contains a CID domain that is also 
specific to serine 2 phosphorylated CTD and is thought to help recruit CFIA factors along 
with Pcf11 [117, 118]. After recruitment, CFIA proteins RNA14 in complex with RNA15 
bind the G/U rich region of RNA near the site of termination [262]. In addition, RNA14 
has been shown to specifically interact with the CPF protein Cft1 [263]. CFIA and CPF 
complex appear to operate in a concerted manner where by Fip1 binds to U-rich regions 
near the site of termination, and Cft1 and Yth1 bind to the termination site specifically at 
the polyadenylation poly(A) site, AAUAA, to induce pausing of RNAPII [263-267]. 
During the pause another CPF protein the endonuclease, Ysh1, which cleaves the 3’ end 
of the newly transcribed RNA at the poly(A) site [110, 268, 269]. The newly cleaved 
RNA then becomes polyadenylated at the 3’ end by the Pap1 enzyme, and requires CPF 
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Table 1: Transcript classes and characteristics. Table includes names of transcripts with 
the mechanism in which they are terminated and degraded as well as their stability in a 
wild-type cell. RNA classes are cryptic unstable transcripts (CUTs). stable unannotated 
transcripts (SUTs) and Ssu72 restricted transcripts (SRTs). Table adapted from: Odil 
Porrua and Domenico Libri, Nature Reviews Molecular Cell Biology 16, 190–202 (2015) 
[12, 13, 159, 181, 240, 272-274]  
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CPF protein Fip1 also has been shown to interact with and stimulate Pap1 activity [267].  
Although there has been much progress in understanding the mechanisms of 
termination, but there is still much that is not yet known. The CPF complex contains 15 
protein members, but many of their exact functions are not yet known even despite 
evidence that all are involved in the 3’ end processing of the nascent protein coding RNA 
or termination [275]. Many of the CPF proteins form distinct subcomplexes within the 
complex such as the associated with Pta1 (APT) complex which consists of Swd2, Ref2, 
Glc7, Pti1, Ssu72, Pta1, and Syc1. This assembly was discovered through affinity 
purification experiments [256]. The APT complex contains many proteins whose 
functions in 3’ end processing of RNA is not understood. However, proteins like the 
phosphatase Ssu72 are known to be involved in other important transcription processes 
such as serine 5 and serine 7 CTD dephosphorylation, gene looping, and read-through of 
termination of ncRNA [13, 185, 201, 276, 277]. Swd2 is also known to be a subunit in 
the Set1C histone H3K4 methyltransferase complex, and although it does not participate 
in polyadenylation of the RNA, it is thought to cause defects in termination [278, 279]. 
Ref2 is an unspecific RNA binding protein that appears to increase stability of the protein 
coding 3’ end processing proteins at inefficient poly(A) sites as well as at ncRNA 3’ end 
sites [280, 281]. Pti1 also was found to be involved in the 3’ end processing of ncRNA 
[281]. Pta1 is required for cleavage and polyadenylation of the protein coding RNA and 
is thought to facilitate the assembly of other CPF subunits that are directly involved in the 
cleavage and polyadenylation of RNA [112]. Syc1, which is homologous for the C-
terminus of Ysh1, was recently shown to be necessary to create an exclusive sub complex 
of CPF that contains only the APT members of the CPF; removal of Syc1 increases 
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cleavage and polyadenylation activity [269, 282]. Syc1 also appears to preferentially 
crosslink to small nuclear RNA (SNR) genes, and removal of Syc1 reduces SNR 
transcript expression in the cell [282]. Thus, all these data are suggestive that the CPF 
may work in two or more separate subcomplexes that include different sets of proteins to 
process different classes of transcripts. A lot of key information is missing to fully 
understand the mechanism of either poly(A)-dependent or poly(A)-independent 
termination. Recently a technically advanced method has been able to separate and 
identify sub-groups of the CPF complex and more accurately identify which proteins are 
in these different groups. Using cryogenic electron microscopy (cryo-EM) and non-
covalent nanoelectrospray ionization mass spectrometry (nanoESI-MS), the Passmore lab 
was able to separate the CPF complex into 3 modules named APT/phosphatase(Ssu72, 
Pta1, Syc1, Swd2, Glc7, Ref2, Pti1), nuclease(Ysh1, Cft2, and Mpe1), and the poly(A) 
polymerase module(Pap1, Cft1, Yth1, Fip1, and Pfs2) [283, 284].  
 
CTD Phosphatases  
Known regulators of the CTD include a number of phosphatases and kinases. 
Some have multiple targets while others have only one known target. The known serine 
kinases in S. cerevisiae include Kin28(S5P/S7P), Bur1(S2P/S5P/S7P), and 
Ctk1(S2P/S5P/S7P). The known serine phosphatases include TFIIF associating 
component of CTD phosphatase, Fcp1(S2P/S5P), regulator of transcription 1, Rtr1 (S5P), 
and suppressor of Sua7 gene 2, Ssu72(S5P/S7P). Like the kinases the phosphatases play 
an equally important role in regulating the CTD and consequently RNA transcription. 
S5P is essential residue of the CTD, and serine 5 is the most highly phosphorylated 
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residue [166, 168]. There is substantial evidence that the phosphorylation state of serine 5 
of the CTD plays a significant role in the fate of transcription, especially with short 
ncRNA transcripts, which are regulated by the NNS pathway; yet the understanding of 
the major players of transcription and their specific roles are still unclear.  
 
1. Fcp1 Phosphatase 
Fcp1 is an essential protein in yeast and was the first CTD phosphatase to be 
identified to convert a phosphorylated form of RNAPII to an unphosphorylated version 
[285-287]. Fcp1 can dephosphorylate both S2P as well as S5P but displays a ~6-fold 
preference for S2P and prefers an S2P-P3 motif to be in trans conformation [173, 288, 
289]. Mutation of Fcp1 in the CTD binding pocket that reduce specificity for S5P did not 
result in growth defects in yeast; however, reduction in S2P does have an effect on yeast 
growth insinuating that Fcp1’s main purpose is to dephosphorylate S2P and its ability to 
dephosphorylate S5P may be nonspecific [189]. Fcp1 has also been shown to interact 
with the catalytic core of RNAPII as well as TFIIF, which is thought to stimulate its 
phosphatase activity [286, 290-293]. The presence of Fcp1 stimulates transcription in 
vivo and in vitro and work done in John Lis’s group has shown that depletion of Fcp1 
leads to an accumulation of nonchromatin bound phosphorylated RNAPII and decreasing 
amounts of unphosphorylated RNAPII, which is required to initiate transcription [189, 





2. Rtr1 and Ssu72 Phosphatases 
 Currently, there are two main phosphatases that target phosphorylated serine 5 
Rtr1 and Ssu72 [34, 201, 203, 205-207]. SSU72 is as an essential gene conserved across 
eukaryotes, and in vivo studies have found that Ssu72 and the scaffold protein Pta1 are a 
part of the CPF complex [13, 216, 256, 276, 277, 296-300]. Several experiments have 
linked Ssu72 to separate mechanisms of transcription including: initiation, RNA 3’ end 
processing, termination, cleavage and polyadenylation in complex with CPF, elongation, 
and gene-looping [13, 256, 276, 277, 297-300]. Ssu72’s role in transcription has even led 
one group to describe a set of transcripts, which they labeled as Ssu72 restricted 
transcripts (SRTs), they discovered using tiling arrays in an Ssu72-R129A mutant which 
were not present in the cell in the wild-type [13]. Rtr1 and the human homolog RPAP2 
were initially found to interact with RNAPII in mass spectrometry experiments; in 
addition, ChIP-seq assays revealed that Rtr1 localized at protein coding genes at similar 
regions that ChIP-seq experiments identified where serine 5 was phosphorylated [203, 
301]. Rtr1 is a phosphatase that has been shown to dephosphorylate serine 5 in vivo and 
in vitro using serine 5 specific antibodies [203]. The phosphatase activity of Rtr1 was 
recently confirmed with a crystal structure that reveals a binding pocket with a trapped 
sulfate ion, a potential site for phosphate group binding [205]. Irani et al. identified an 
amino acid substitution, Y105A, in this binding pocket that reduced the phosphatase 
activity 40-fold [205]. Using ChIP-chip experiments with a serine 5 phosphorylated CTD 
antibody one group was able to quantify serine 5 phosphorylation at set regions along a 
gene based on the amount of DNA that was immunoprecipitated along with the S5P CTD 
antibody [302]. This group calculated the average number of DNA reads, which represent 
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the amount of S5P, found at each region of the genes in an rtr1Δ and WT strain. Their 
data displayed an increased average of S5P at the 3’ end of the genes which implies that 
there is a global 3’ shift in localization on average across all genes in the genome when 
Rtr1 is removed which gives further evidence that Rtr1 has a major impact in the 
distribution of serine 5 phosphorylation of the CTD [302]. Both phosphatases Rtr1 and 
Ssu72 appear to have the same serine 5 target, yet S. cerevisiae strains with an RTR1 
deletion or a Ssu72 mutation seem to have contrasting effects. ChIP assays using an Rtr1 
antibody show that on most genes Rtr1 accumulates during early elongation while an 
Ssu72 antibody most often finds Ssu72 accumulating at the middle to late elongation 
[185, 203]. The difference in timing of phosphatase activity could be due to the necessity 
for proline 6 to be isomerized, by Ess1, into the cis state for Ssu72 to have a higher 
affinity for a serine 5 phosphorylated CTD and to be more efficient in the 
dephosphorylation of the serine 5 [184, 216, 217, 303-305]. However, since Rtr1 acts 
first when phosphorylated serine 5 is most abundant, Rtr1 might play a greater role in 
fine-tuning the activity of RNAPII, thus deciding the fate of most transcripts. Ssu72 
might be more responsible for coarse tuning and RNAPII recycling which could be 
essential for transcription termination.  
 
Mass Spectrometry 
Today mass spectrometry is utilized for studying several fields of biology. In 
addition, the field of mass spectrometry is producing new methodology to answer 
questions that could have never been answered before as exemplified with 
multidimensional protein identification technology (MudPIT), affinity purification mass 
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spectrometry (AP-MS), and nanoESI-MS as mentioned previously in the CPF modules 
study [283, 284, 306]. 
 
1. MudPIT and AP-MS 
The use of mass spectrometry in biological experiments started becoming more 
common after DNA and RNA sequencing became prevalent. Just as scientists began to 
look at mRNA differences in a cell, many started to realize that looking at the end 
product of mRNA could also be analyzed in a similar way. In addition, there is evidence 
that the abundance of mRNA and the corresponding proteins may not be correlated [307-
310]. Thus, there was a push to be able to emulate RNA sequencing methodology with 
mass spectrometers. Some of the limiting factors that scientists sought out to address 
were; low abundance of certain proteins, the ability to detect membrane proteins, to 
detect proteins with very low/high isoelectric points, and to identify proteins with a very 
large or small mass [311-316]. Several methods were developed to overcome these 
problems including a more efficient separation of complex protein mixtures such as 
MudPIT([317]. By using this method, scientists can measure protein levels of whole 
proteomes and compare proteomes of different cells in different conditions or mutations 
as well as analyze more complex set of protein mixtures [318-323]. The MudPIT method 
utilizes a bi/triphasic microcapillary column packed with chromatographic phases, such 
as hydrophobic stationary or reversed-phase (RP) resin and strong cation exchange resin 
(SCX) that separate peptides based on their chemical and physical qualities. The column 
is then linked to a high-performance liquid chromatography (HPLC) instrument and 
coupled to a tandem mass spectrometer[317, 324]). The peptides are pressure loaded onto 
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the packed microcapillary column and then eluted into the mass spectrometer using an 
organic phase gradient such as acetonitrile with the HPLC.  
Then the peptides are ionized by applying a continuous high voltage (2–6 kV) via 
a nano-electrospray ionization (nano-ESI) source to the eluting peptides [325-327]. The 
peptides are then fragmented in a predictable fashion once or multiple times in the 
tandem mass spectrometer via collision induced dissociation (CID), high energy collision 
induced dissociation (HCD) or electron transfer dissociation (ETD) [328, 329]. The 
resulting fragment ions can then be detected by their mass and charge using components 
inside the mass spectrometer such as an Ion trap, an Orbitrap, or ion cyclotron resonance 
(ICR) mass analyzer [330, 331]. The resulting data generates spectra for each peptide 
which is then analyzed by a computer, and each spectra profile is compared to a database 
of peptides of possible amino acid sequences in different species using an algorithm such 
as SEQUEST that produce peptide spectral matches (PSMs) and the probability that these 
PSM’s are true matches [332]. 
AP-MS is another method that has been instrumental in many researchers’ 
discoveries over the years [333-336]. This method allows scientists to analyze and map 
convoluted protein-protein interactions (PPIs) in a cell. Simplification of the proteome is 
achieved by isolating proteins of interest and then detecting the proteins that interact with 
them (Figure 5). The affinity purification can be altered to increase or decrease specificity 
that can serve to give a more complete picture of proteins that interact with the bait 





Figure 5: Affinity purification mass spectrometry schematic. Flag-tagged protein is 
immunoprecipitated using anti-flag beads, then washed on a column to remove non-
specific binding of proteins. Flag peptide is added to remove immunoprecipitated 
proteins from beads through competitive elution. Proteins are collected and then digested 
using trypsin and Lys-c to create peptides for the mass spectrometer. 
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2. Cross-Linking Mass Spectrometry 
Structural studies are incredibly useful at providing information about proteins; 
yet protein structures are difficult to solve, and they take a significant amount of time to 
complete, due to their difficulty in forming crystals, protein flexibility, low solubility and 
large size [337]. With increasing complexity the difficulty rises tremendously [337]. An 
emerging method to study the architecture of proteins and their interacting partners is to 
chemically cross-link the proteins of interest and then use mass spectrometry (XL-MS) to 
identify where proteins are cross-linking either to themselves or to other proteins [338-
341]. In this method, proteins are chemically cross-linked, enzymatically digested and 
then the resulting sample is processed by liquid chromatography tandem mass 
spectrometry LC-MS/MS or LC-MS/MS/MS by ESI. Using this method, the mass 
spectrometer can identify which amino acids are cross-linked by identifying peptides 
which contain the mass of the crosslinker. The short length of the crosslinker gives this 
method the ability to identify where these proteins may be interacting thus giving insight 
to the structural architecture of the protein itself and in relation to other proteins. 
Identifications of interactions are restricted by the crosslinker and the amino acids that it 
can crosslink to. However, many different crosslinkers of varying specificity and length 
are currently available and many new crosslinkers are currently in development. This 
method is both fast and inexpensive and many different proteins and mutations of the 
same protein could be analyzed quickly. A limiting factor for XL-MS is the efficiency of 
the technique; thus, quantity of sample may be an issue. Some crosslinkers recommend to 
use between 10µM-500µM quantities of purified protein. For XL-MS, a commonly used 
crosslinker for many studies has been Bissulfosuccinimidyl suberate (BS3). BS3 requires 
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the computation of a pre-determined peptide library of possible crosslinks, which can 
lead to an incomplete/limited library of possible crosslinked peptides or a large 
computational task which would be unfeasible and/or inefficient for complex mixtures of 
peptides [342-345].    
Another XL-MS method is one that uses a CID labile MS cleavable, cell 
membrane permeable crosslinker called Disuccinimidyl sulfoxide (DSSO), which has a 
spacer length of 10.1 Å [346, 347]. The DSSO crosslinker contains two amine reactive 
N-hydroxysuccinimide (NHS) ester groups at the ends of the molecule, which target 
lysine residues, and a sulfoxide in the spacer region which has the ability to be cleaved 
inside the mass spectrometer through low energy CID levels without cleaving the peptide 
bonds. NHS esters have also been observed to react with hydroxyl groups in serines, 
threonines, and tyrosines but only at 20% of their reactivity with lysines and so it may be 
possible to gain more information from these experiments where the number of crosslinks 
have been relatively scarce [348]. After cleavage each crosslinked parent peptide stays 
intact while leaving two distinct modifications on lysines, a carbonyl group with either a 
thiol group or an alkene group at the end. The difference in mass between the two groups 
is 32 daltons, this mass difference is used to identify true crosslinked peptides. The ability 
to cleave the crosslinker inside the MS and then identify crosslinked peptides as 
modifications of the original peptide give the crosslinker a huge advantage in that 
massive computing power or a computationally predetermined library of crosslinked 
peptides are unnecessary. The feature allows the DSSO crosslinker to be used to identify 
a more diverse and complex set of crosslinked samples. 
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Investigating the Role of Rtr1 and Ssu72 in RNAPII Transcription Termination  
The highly regulated process of transcription requires an array of proteins and 
protein complexes. These proteins can be specific or non-specific, unique or redundant, 
essential or non-essential. In order to better understand the transcription process as a 
whole, it is important to understand all of the components of the process, and each 
component’s individual role. The RNAPII CTD is an essential hub for recruitment of 
proteins and the regulation of RNAPII transcription. RNAPII CTD hyperphosphorylation 
at serine 5 is required for transcription to initiate, which then undergoes 
dephosphorylation as transcription progresses through the gene and is likely required for 
transcription termination to occur. Currently only two phosphatases, Rtr1 and Ssu72, are 
known to dephosphorylate serine 5 on the RNAPII CTD. However, their mechanism of 
action is still unknown and it has yet to be discerned whether these phosphatases target 
the same S5P CTD or whether their dephosphorylation incurs the same downstream 
effect on transcription. 
Past research based on ChIP assays suggests that Rtr1 likely acts during early 
elongation, while Ssu72 acts in mid/late elongation [34, 201, 203, 296, 349]. ChIP assays 
with antibodies specific to Rtr1, serine 5 phosphorylation and Ssu72 show that Rtr1 and 
serine 5 phosphorylation are most often found to be associated with 5’ end of genes, 
Ssu72 is predominantly associated with the 3’ region [184, 185, 203, 217]. My central 
hypothesis is that Rtr1 and Ssu72 play a major and unique role in the regulation of early 
termination through dephosphorylation of the RNAPII CTD and thereby effect 
recruitment of the NNS termination pathway or other downstream proteins. In addition, I  
believe that Ssu72 plays an additional key role in transcription that is separate and 
downstream of Rtr1’s role, specifically with Ssu72’s associated complex CPF in PolyA 
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dependent termination. To study the effect of Ssu72 on transcription, I used a termination 
deficient strain of Saccharomyces cerevisiae originally named ssu72-tov (termination 
override) which I refer to as Ssu72-L84F [350, 351]. I studied Rtr1’s role in transcription 
using an rtr1Δ yeast strain.  
In order to study the direct effect that Rtr1 and Ssu72 have on the transcription 
process and the RNA product I used a termination defective Ssu72-L84F and rtr1Δ 
mutant strain to analyze differentially expressed genes with a particular focus on NNS 
termination targets. To analyze the phosphatases effect on RNAPII specifically and to 
confirm whether RNAPII continues to transcribe beyond different termination signals 
globally, in the Ssu72-L84F and rtr1Δ strain, I measured the abundance of RNAPII 
occupancy using a method called ChIP-exo, a high resolution chromatin IP (ChIP) 
method [352].  In order to study the protein network that Rtr1 and Ssu72 are involved in I 
used MudPIT-LC/MS/MS to analyze the effects that the Ssu72-L84F and rtr1Δ strain 
have on the interactions observed with transcription proteins compared to a wild-type 
strain. I used Significance Analysis of Interactome (SAINT) to identify statistically 
significant interactions in all samples and to remove low confidence interactions using 







Yeast Strain Production 
Yeast strains were created using the established BY4742 strain as parental and are 
listed in Table 2. BY4742 and the rrp6Δ strain were acquired from Open Biosystems. 
The Ssu72-L84F and nrd1Δ151-214 strains were acquired from Danny Reines. All cells 
were grown in 10 grams of yeast extract 20 grams of peptone and 100 ml of 20% glucose 
known as YPD or a selective synthetic drop-out media (when indicated) at 30°C. The 
FLAG-tagged strains were created through transformation of a cassette containing three 
semi-repetitive FLAG sequences, DYKDHDG-DYKDHDI-DYKDDDDK, downstream 
of a URA3 gene in the pBS1539 construct (Table 3). This cassette was created with 
primers with homology to the 3’ UTR region of RPB3 and the pBS1539 plasmid. Stable 
incorporation of the FLAG tag was confirmed via Western blot using an anti-FLAG 
antibody (A8592 Sigma). The strains with a 3C protease cleavage site inserted into Rpb1 
were made using an Agilent Quickchange Lightning Kit. The 3C cleavage sequence, 
LEVLFQ/GP, was inserted at amino acid 1460 of Rpb1, into the linker region of RPB1 in 
an RPB1 pENTR-D-TOPO construct and confirmed via sequencing. The construct was 
then transformed into a wild type strain with a 3XFLAG tagged RPB3. RTR1 was 
knocked out of wild type and the rrp6Δ strain by homologous recombination with a 
kanamycin cassette to create the RTR1 deletion and rtr1Δ/rrp6Δ double deletion strains. 
rrp6Δ strain is from the yeast knockout collection (Open Biosystems) [354]. The Rpb3-
3xFLAG (referred to as Rpb3-FLAG) WT strain has been previously described [57]. The 
Nrd1-TAP strain is from the yeast TAP-tag collection (Open Biosystems). The Rpb3-
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FLAG and Nrd1-TAP rtr1Δ strains were made by amplification of the RTR1 knockout 
cassette from the rtr1Δ strain and transformation into the wild-type Rpb3-FLAG and 
Nrd1-TAP strains respectively. All deletion strains were confirmed by PCR-based 
genotyping. To perform a single biological replicate for genomics or proteomics 
experiments, growths of all strains of interest were pre-cultured from a single colony 
obtained from a sequence-verified glycerol stock of the strain that had been plated on the 
appropriate selective medium and grown for 2 days. Liquid cultures of all genotypes for 
an individual biological experiment were grown up on the same day. Cells for subsequent 
biological replicates were grown on different days. 
 
Affinity Purification of Protein Complexes 
Cells were grown to OD600 ≅ 1.5 in YPD broth overnight and collected by 
centrifugation for 10 minutes at 4000 x g, washed in H2O, and resuspended in 10 mL 
TAP lysis buffer (40mM Hepes-KOH, pH 7.5; 10% glycerol; 350mM NaCl; 0.1% 
Tween-20; fresh yeast protease inhibitors (Sigma; diluted to 1X)) per 1 gram of cell 
pellet. The cells were slowly transferred into liquid nitrogen using a syringe. The frozen 
cells were pulverized with a mortar and pestle and lysed further in a Waring Blender with 
dry ice. The frozen lysate was transferred to a new container and allowed to thaw at room 
temperature. The resulting extract was treated with 100units DNase I and 10µL of 
30mg/mL heparin for 10 minutes at room temperature and clarified by centrifugation as 
previously described [355].   
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Table 2: Yeast strains. Table of yeast strains, genotype and origin 
 
  
Name Genotype Source  
BY4742 MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 Open Biosystems 
yAM522  MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 RPB3-FLAG::URA3 This Study 
yAM334 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 RPB3-FLAG::URA3  This Study 
yAM423 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 RPB3-FLAG::URA3 RPB1::3C This Study 
2D1F MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 ssu72g.252A>T D. Reines-Emory U. 
yAM421 MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 ssu72g.252A>T RPB3-FLAG::URA3 This Study  
yAM486 MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 ssu72g.252A>T RPB3-FLAG::URA3 RPB1::3C This Study 
YSB2078 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 nrd1Δ151-214 D. Reines-Emory U. 
BY4741 





Primer  Sequence  
SSU72_L84F_FORWARD  5’- CGATCCAGCATTTGCAAGAAACC GTTCG-3’  
SSU72_L84F_REV  5’-GTTACAAGTCGAACGGTTTCTTGCAAATG-3’ 
SSU72_L84A_FORWARD  5’-ACGATCCAGCATTTGCAATGCACCGTTC-3’ 
SSU72_L84A_REV 5’-CCGTTACAAGTCGAACGGTGCATTGCAA-3’ 
SSU72 C15S REVERSE 5’-CGCATTTCAAACTTGAAGTTTTGCACAGTTTC TGCATCAAACAACAAT-3’  
SSU72 C15S FORWARD  5’- ATTGTTGTTTGATGCAGAAACTGTGCAAAAC TTCAAGTTTGAATTGCG-3’  












GST_544 TO 563 5’-CGTATTGAAGCTATCCCACA-3’ 
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Table 3: Primers. Primers used to create strains and Northern probes 
 
  





YKL151C AS PROBE R 5’-TAAGGGACAGTCTGGTGGGAGAGTTTGC-3’  
YKL151C S PROBE F  5’-CACCTCCGAGATGGGCAGCTTGATC-3’  
YKL151C S PROBE R 5’-TAGCGsTAGTCTACCCAGTTTTTCAGG-3’   
YKL151C AS PROBE F 5’-CACCGCTACTTGTGGAGTTATTAATTGCACT     G-3’  
YKL151C AS PROBE R 5’-GGTGGCTTTTTCTCAGTTTCGTGGGC-3’   
YKL151C AS PROBE F 5’-CACCGCGACCTACAGCCGATGTCTTGACAG   G-3’   
YKL151C AS PROBE R 5’-GTTGGCCGGTACTACCGAATCACCAGG-3’   




GGACAAGATGGTGGCGTCACACCA-3’    




GACTCCTCATCGATCATCACATCAAA-3’    
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Affinity purification was performed as previously described [355]. For FLAG-tagged 
purifications, the lysate was incubated with anti-FLAG agarose resin (Sigma) at 4°C 
overnight. The resin and bound proteins were removed from the lysate by gravity flow 
through a 30mL Bio-Rad Econoprep column and washed on the column with 60 mL TAP 
lysis buffer. The resin was resuspended in 300µL of 50mM Ammonium bicarbonate pH 
8.0 and transferred to a microcentrifuge tube for on-bead digestion with 5µL of Trypsin 
Gold (0.1µg/µL) overnight with shaking at 37°C. The supernatant containing the digested 
proteins was removed and treated with 20µL of 90% formic acid to inactivate the trypsin.  
 
MudPIT-LC/MS/MS and Proteomics Data Analysis 
  Each affinity purified sample was loaded onto a two-phase MudPIT column 
containing strong cation exchange resin (Phenomenex), which binds positively charged 
ions, and reverse phase C18 resin (Phenomenex), which retains peptides based on their 
hydrophobicity [356]. The samples were eluted off the column by a MudPIT protocol of 
10 steps of increasing salt concentrations (50-350mM ammonium acetate) followed by an 
organic gradient (20-80% acetonitrile). All chromatography solutions also contained 1% 
formic acid. Peptides were analyzed by a ThermoFisher LTQ Velos for MS/MS analysis. 
Raw spectrum data from the MS analysis were submitted for protein identification by 
Proteome Discoverer software (Thermo) version 2.1 using SEQUEST-HT as the database 
search algorithm. Database searches were performed against a FASTA database from the 
yeast Uniprot proteome. The FASTA database also included a number of common 
protein contaminants such as keratins and IgGs. 
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Disruption - Compensation (DisCo) Network Analysis  
Disruption-Compensation (DisCo) analysis using protein-protein interaction tools 
to analyze protein-protein interaction dynamics as a consequence of genetic perturbation, 
in this case deletion of the CTD phosphatase RTR1. Statistical analysis of interactome 
(SAINT) was performed as previously described on at least four biological replicate 
purifications from each genotype [357-359]. In brief, PSMs for each co-purified protein 
were annotated per purification by bait protein, genotype (WT or ‘rtr1D’ for rtr1Δ), and 
replicate in the list format required for SAINT analysis on crapome.org [360]. 
SAINTexpress was used for the probability score calculation [358]. The output file from 
SAINT analysis was uploaded to ProHits-viz for prey-prey correlation analysis with the 
following key options: Abundance column = Spec (i.e. PSM), Score column = Saint 
score, Abundance cutoff for prey correlation = 20, Add bait counts = yes [361].  
 
Global Proteome Abundance Analysis 
WT and rtr1Δ cells were lysed in 8M urea in 100mM Tris pH 8.5 for optimal 
protein extraction. Samples were digested using Trypsin Gold (Promega) and labeled 
with Tandem Mass Tag (TMT) reagents according to the manufacturer’s protocols 
(Thermo Fisher). TMT labeled peptide samples were combined for multiplexing, then 
subjected to high pH reversed phase fractionation (8 fractions). The fractions were 
analyzed on an Orbitrap Fusion Lumos instrument using an SPS MS3 method and the 
data searched on Proteome Discoverer 2.3 using a yeast proteome downloaded from 
Uniprot in October 2017. The protein abundances were normalized using total peptide 
amounts per multiplexed channel. 
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Transformation of Wild Type Plasmid DNA into E. coli 
Wild type SSU72 DNA (pGST-SSU72 wild type supplied by the Faye lab) was 
purified from One Shot® chemically competent E. coli cells using a GeneJET Plasmid 
Miniprep Kit (Thermo K0503) (Table 4). An Agilent Quickchange Lightning Kit was 
used to conduct site directed mutagenesis of SSU72 from TTA to TTC (L84F) and GCA 
(L84A) and from TGT to TCT (C15S). Rosetta 2(DES) pLys(s) cells were transformed 
with pGST-SSU72-L84A pGST-SSU72-L84F plasmids and pGST-Ssu72-C15S plasmids. 
The sequence of the mutated DNA was confirmed through third-party Sanger Sequencing 
(Genewiz).  
 
RNAPII CTD 3C cleavage  
Yeast cultures were grown to an OD600 of 3.5. After harvesting cells, each strain 
was resuspended in 10 times the cell pellet volume of TAP lysis buffer (40 mM HEPES-
KOH, pH 7.5; 10% glycerol; 200 mM NaCl; 0.1% Tween-20; protease inhibitors (Sigma 
P8215); 1 mM sodium orthovanadate) and lysed via bead-beating. After lysis, each 
sample was treated with 100 units of DNase I and 0.3 µg of heparin to solubilize 
chromatin. Each extract was clarified by centrifugation for 1 hour at 13,000 rpm. The 
clarified lysate from each strain was incubated with 500 µL Anti Flag M2 (Sigma A2220) 
affinity resin for at least 3 hours. After incubation, each sample was applied to a Bio Rad 
Econo-Pac (7321010) column and allowed to drain via gravity.   
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Table 4: Plasmids. Table of plasmids created and used for experiments. 
 
  
Stock ID  Backbone Plasmid  Source 
pAM305  pGEX6P-1 pGST-SSU72-L84F  This Study 
pAM306  pGEX6P-1 pGST-SSU72-L84A  This Study 
pAM311  pGEX6P-1 pGST-SSU72-WT  M. Hampsey-Robert Wood Johnson  
pAM312 pGEX6P-1 pGST-SSU72-C15S M. Hampsey-Robert Wood Johnson 
pAM76 pBS1539 pBS1539 with URA3 at C-terminal Hochstrasser-Yale U. 
pAM11-1 pENTR-D-TOPO  pENTR-D-TOPO RPB1  This Study 
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The resin on the column was then washed with 100 mL of lysis buffer, followed by a 
wash with cleavage buffer (10 mM Tris, pH 8; 150 mM sodium chloride; 0.1% IGEPAL; 
1 mM EDTA; protease inhibitors). Affinity resin from each sample was resuspended in 
500 µL cleavage buffer, with 5 µL of purified 3C protease added. The RNAPII-associated 
proteins, affinity resin, and 3C protease mixture was then incubated overnight on a 
rotating wheel at 4°C. To collect the RNAPII CTD (and associated proteins), each sample 
was again applied to a Bio Rad Econo-Pac column, and washed with 500 µL of cleavage 
buffer that was collected with the CTD/associated proteins. A BCA protein assay was 
performed on both CTD/associated protein samples and to assist in equal protein loading 
onto an SDS-PAGE gel.   
 
Whole Cell Lysate and Ser5, Ser7 Phosphorylation Western blot 
Yeast strains were grown to an OD600 of 3.5. After harvesting cells, each strain 
was lysed in lysis buffer by bead-beating. Each extract was clarified by centrifugation for 
1 hour at 13,000 rpm. After clarification of cell lysate, the supernatant was collected and 
30 µL of each sample was boiled with Laemmli buffer. Samples were then loaded on an 
SDS-PAGE gel and run at 200V. Proteins were transferred to nitrocellulose paper 
overnight at 30V at 4°C. The membranes were then blocked with 5% milk/TBS solution 
for 30 minutes and incubated at 4°C overnight with one of the following primary 
antibodies: anti CTD-phospho-serine 2 (3E10, EMD Millipore), CTD-phospho-serine 5 
(3E8, EMD Millipore), CTD-phospho-serine 7 (4E12, Millipore), or PGK1(459250, 
Invitrogen). Membranes were washed in TBS and incubated with their respective 
secondary antibodies: goat anti-rat (6845, Abcam) or donkey anti-mouse (NA934, GE 
48 
Healthcare). Finally, the membranes were developed using a Pierce ECL 2 kit and 
scanned on a fluorescent image analyzer (FLA-5000, FUJIFILM). 
 
GST-SSU72 Expression in E. coli and Affinity Purification 
The GST-SSU72 plasmid containing strains were grown in LB/ampicillin 
overnight at 37°C and used to inoculate 1L of LB/ampicillin, which was grown to a final 
OD600 of at least 0.8. IPTG was added to a final concentration of 1 mM at which point the 
incubation temperature was shifted to 18°C. After overnight protein expression, cells 
were pelleted and lysed three times at a pressure of ~ 1000 psi (high setting) in a French 
Press high pressure cell press. Lysates were clarified by centrifugation and the 
supernatant was loaded onto a Bio-Rad Econoprep column packed with 1 mL of 
Glutathione Sepharose 4B resin (GE Healthcare). Loading occurred at a rate of 1 mL/min 
using a Bio-Rad chromatography system. After loading, the column was washed with a 
wash buffer solution (50 mM HEPES-KOH, 300 mM NaCl, 10% Glycerol, 10 mM 
EDTA and 1 mM β-mercaptoethanol). A gradient of lysis buffer to 100% wash buffer 
was used at a rate of 1 mL/min for 30 minutes (lysis buffer to wash buffer). After 30 
minutes, the column was washed with 100% wash buffer for another 30 minutes. After 
washing, the GST-tagged protein was eluted from the column using an elution buffer (50 
mM HEPES pH 7.5, 150 mM NaCl, 10 mM EDTA, 0.1-1 mM β-mercaptoethanol, 100 
mM R-glutathione). Elution was conducted using an increasing gradient of elution buffer 
at a rate of 1 mL/min (lysis buffer to elution buffer). Elution fractions (1 mL each) were 
collected each minute as the UV absorbance was recorded. Fractions were combined 
based on the recorded absorbance and transferred to a 7000 MWCO dialysis tube. 
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Dialysis occurred overnight at 2-8°C in 5L of dialysis buffer (50 mM HEPES, 150 mM 
NaCl, 1 mM DTT). The next day, the dialysate was transferred to a 10 kDa spin filter and 
the solution was concentrated to ~1 mL.  
 
In-Vitro Ssu72 Phosphatase Activity Assay 
The phosphatase assay was completed in a Costar black 96 well plate. Each well 
was filled with water, 50 mM succinic acid, 150 mM NaCl, dialysis buffer solution, 2 µΜ 
Ssu72 protein and a final concentration of 10 µM 6,8-difluoro-4-methylumbelliferyl 
phosphate (DiFMUP) in DMSO. After addition of DiFMUP, the plate was analyzed in a 
Molecular Devices Spectramax® M5 plate reader set at 30°C with excitation at 355 nm 
and emission at 455 nm. Glutathione S-Transferase was used as a background control 
(data not shown) 
 
RNA Isolation and Northern analysis 
RNA was isolated from 200 mL cultures grown to an OD600 of 1.0. Cells were 
centrifuged, washed, and then resuspended in 10 mL of AE buffer (50 mM sodium 
acetate at pH 5.2, 10 mM EDTA). RNA was isolated using a hot acid phenol extraction, 
by addition of 800 µL 20% SDS and 10ml cold acid phenol. Cells were incubated at 65°C 
for 10 minutes with constant agitation then incubated at 4°C. The aqueous phase was 
separated via centrifugation and transferred to a gel matrix phase lock tube (Qiagen), 13 
mL of Chloroform was added, and RNA was separated from DNA and other impurities 
via centrifugation. RNA was precipitated with an equal volume of isopropanol and 1/10 
volume sodium acetate. Samples were then analyzed for integrity and quality using an 
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Agilent Bioanalyzer by assessment of ribosomal RNA (rRNA). Afterwards the RNA was 
loaded onto a 1.5 % agarose gel at 30 ug total RNA and imaged with a UV imager (Bio-
Rad ChemiDoc XRS). The RNA was transferred to a Zeta-Probe blotting membrane 
overnight by capillary action and cross-linked by UV light. The membrane was stained 
with methylene blue and de-stained before hybridized with radioactive DNA probes (see 
Table 5). DNA oligonucleotide probes were created using 5’ end-labeled gamma ATP-
32P by T4 Polynucleotide Kinase (Life Technologies) for detection of snRNAs. The 
membrane was pre-hybridized in Roche Life Science DIG Easy Hyb buffer at 37°C. The 
radioactive probes were added to the hybridization buffer and incubated overnight. After 
hybridization, the membranes were washed in 6XSSC / 0.1%SDS once at room 
temperature and twice for 10 minutes at 50°C. Blots were exposed to a phosphorscreen 
overnight for snRNAs followed by scanning using a phosphorimager (GE Healthcare). 
For less abundant transcript types, YKL151C, IMD2 and NRD1 primers were created to 
complement areas of the gene of interest where transcription was expected to occur. 
These primers were used to amplify a region of the gene around 250 nucleotides from the 
genome using PCR. A specific sequence, CACC, was incorporated into the forward 
primer to preserve strand specificity. The PCR product was incorporated into a 
pENTR/D-TOPO (Invitrogen) vector through a topoisomerase reaction and then 
transformed into chemically competent TOP10 cells (Invitrogen). The sequence of the 
PCR product in the pENTR/D-TOPO was confirmed through sequencing. The product 
was then transferred to a pET-DEST42 (Invitrogen) vector using LR recombination and 
transformed into TOP10 cells. The sequence of the PCR product in the pET-DEST42 
vector was confirmed through sequencing. The PCR product and vector were isolated and 
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the PCR product was amplified with a T7 enzyme (MAXIscript) using P32 labeled UTP. 
The radiolabeled probe was hybridized to the RNA blot at 68˚C overnight. Next, the 
membranes were washed with 1xSSC/0.1%SDS twice at room temperature and twice 
with 0.1xSSC/0.1%SDS for 15 minutes at 68°C. Blots were exposed to a phosphorscreen 
overnight for 7 days followed by scanning using a phosphorimager (GE Healthcare). 
 
RNA Sequencing and Analysis 
After total RNA isolation, the RNA was DNase treated using an Ambion DNase-
turbo kit. Samples were then analyzed for integrity and quality using an Agilent 
Bioanalyzer by assessment of ribosomal RNA (rRNA). After identifying high quality 
RNA, the samples were given to the Medical Genomics Core at the Indiana University 
School of Medicine (IUSM). At the core, 5 µg of each RNA sample were treated with 
the ERCC ExFold RNA Spike-In Mixes from Ambion, which included known 
concentrations of RNA, to all of the samples in order to control for total RNA variation. 
Samples were then depleted of ribosomal RNA with Ribo-Zero Magnetic Gold Kit. 
Afterwards cDNA libraries were prepared following the TruSeq Stranded Total RNA 
Sample Preparation Guide from Illumina and sequenced with the Illumina HiSeq 4000. 
Raw sequencing results were analyzed for quality and aligned to the yeast genome. On 
average each sample had ~30 million 75bp paired-end reads. The analysis was strand-
specific and compared RNA expression first by normalizing according to the spike-in 
ratios stated in the ERCC ExFold kit and then using the edgeR program to normalize and 
analyze differential expression [362].   
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Table 5: RNA probes. Nucleotide sequence of probes used for Northern blots 
Name  Sequence  
snR13 Probe  5’-GCC AAA CAG CAA CTC GAG CCA AAT GCA CTC-3’    
snR3 Probe  5’-GCT CGA TCT TCG TAC TGT CTA ATG CGG TGG-3’    
snR11 Probe  5’-CTA TCA ACC GCG AGC ACG ACA GTG-3’    
snR82 Probe 5’-GCT TGG ATC CAA GAA AAA CTC CCG GTA ACC AGG-3’    
snR33 Probe 5’-GCT AGG CTT TCA ATC TCT GCT CCT CCA AAC-3’    
snR71 Probe 5’-GAT GAT AAC CTT CTC AGC TCA CTC AGA TC-3’    
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An extended set of annotations that includes 5’ and 3’ UTR regions of genes as 
well as previously published annotations of ncRNAs, such as cryptic unstable transcripts 
(CUTs) and Ssu72 restricted transcripts (SRTs), were utilized, which total over 12,000 
genes, to analyze differential expression [12, 13].  The edgeR program calculated 
normalization parameters as well as performed statistical analysis of the data using an 
overdispersed Poisson model, and an empirical Bayes procedure with a cut off for low 
read counts of 100 reads per gene [362]. These results were used for the volcano plot. 
Read counts per nucleotide for individual genes were calculated using the bedcov 
command in samtools [363]. A separate set of annotations taken from Tan-Wong et al. 
was used to compare the differential expression of the Ssu72-R129A mutant conferring 
the appearance of SRT’s to the differential expression seen in the Ssu72-L84F mutant 
[13].  
 
ChIP-exo and MNase-seq  
ChIP-exo was developed to obtain high resolution data from chromatin 
immunoprecipitation (ChIP) followed by sequencing. This is achieved by the addition of 
lambda exonuclease (a dsDNA 5’ to 3’ exonuclease) and RecJf (a ssDNA 5’ to 3’ 
exonuclease) following annealing of the first primer set to digest the 5’ end of unbound 
DNA and decrease the length of the DNA bound to RNAPII, thus increasing the 
resolution of the sequences at which RNAPII is bound on the genome (Figure 6) [20, 
352]. 
ChIP-exo was performed as previously described [20, 352]. Briefly cells were 
grown in a 200 mL YPD culture to an OD600 of 0.8 and crosslinked with formaldehyde 
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(1%) (Sigma F8775– 25ML) for 15 minutes. Cells were then collected and lysed, and 
chromatin was sonicated to attain DNA fragments of 100-500 base pairs and visualized 
with the Agilent Bioanalyzer. Immunoprecipitation was done with 50 µL of anti-FLAG 
agarose resin. The chromatin was then barcoded with DNA adaptors and treated with 
lambda exonuclease and RecJf, thereby digesting the 5’ end of unbound DNA. Chromatin 
was then un-crosslinked, isolated using chloroform and precipitated with ethanol.  
Micrococcal nuclease (MNase) digestion and sequencing was performed through 
adaptation of the protocol by Wal and Pugh [364]. Following optimization of the 
digestion conditions, 15U of MNase was added to a chromatin slurry and incubated with 
shaking at 37 °C for 20 minutes. The digestion was quenched by addition of 50 mM 
EDTA and 0.2% SDS. The digested DNA was cleaned up through phenol/chloroform 
extraction followed by ethanol precipitation with 20ug of glycogen (Sigma) as a carrier. 
ChIP-exo and MNase library construction, EZBead preparation, and Next-Gen 
sequencing were completed using standard methods based on the Life Technologies 
SOLiD5500xl system as previously described. 
 
ChIP-exo Sequencing and Analysis 
Samples were sent to the IUSM Medical Genomics Core for sequencing. EZBead 
preparation and sequencing were performed on Life Technologies SOLiD5000xl system 
as specified previously [20, 248]. Raw sequencing results, with an average of 40 million 
75bp single-read reads per sample, were analyzed for quality and aligned to the yeast 




Figure 6: Chromatin immunoprecipitation and exonuclease analysis (ChIP-exo) 
workflow. RNAPII is immunoprecipitated, chromatin is sheared and double stranded 
DNA has 5’ ends digested by Lambda exonuclease up to RNAPII creating a footprint up 
to nucleotide resolution of where RNAPII is located on the DNA. 
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Aligned results were then analyzed for differential localization of each gene using EdgeR 
similar to the RNA differential expression analysis. Average gene analysis was done 
using NGS.plot [365]. Different transcript types were grouped and averaged using 
NGS.plot for each gene for that particular group along the window specified. Before 
averaging read counts, all reads from each sample were normalized to each other by total 
read counts of each sample. Read counts per nucleotide for individual genes were 
calculated using the count command in the bamutils tool which is a part of the ngsutils 
package [366]. 
 
Cross-linking Mass Spectrometry  
Cells were grown to OD600 ≅ 2.5 in YPD broth overnight. The cells were then 
collected by centrifugation for 5 minutes at 3000 x g, washed with H2O, and pelleted via 
centrifugation at 3000 x g for 5 minutes before being stored in 50 mL falcon tubes at - 
80°C. Frozen cell pellets were thawed and transferred to liquid nitrogen dropwise using a 
syringe. The frozen cell droplets underwent cryogenic grinding using the Cryomill 
(Restch). TAP lysis buffer (40 mM HEPES -KOH, pH 7.5; 10% glycerol; 350 mM NaCl; 
0.1% Tween-20) and yeast protease inhibitor (Sigma; diluted to 1X) were added to cells 
at room temperature. Cells were centrifuged at 14,000 x g for 1 hour. The lysate was then 
transferred to a new container and incubated with TAP lysis buffer washed anti-FLAG 
agarose resin (Sigma) at 4°C overnight. The resin and associated proteins were then 
removed from the lysate by gravity flow through a 30 mL Bio-Rad Econoprep column. 
The column was then washed with 120 mL of TAP lysis buffer followed by two 
additional washes with 500 µL of 20 µL HEPES buffer. During the second wash, the 
HEPES buffer was retained in the column so that 2 mg of disuccinimidyl sulfoxide 
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(DSSO) dissolved in 102 µL could be added to the protein solution. The solution was 
incubated on the column at room temperature for one hour. 10 µL of tris was added and 
the resin and associated proteins were extracted with 200 µL of 8 M urea prior to transfer 
to a 1.5 mL microcentrifuge tube. 10 µL of TCEP was then added to the protein sample 
which was then left to incubate at room temperature for 30 minutes. This was followed 
by an addition of 3 µL CAM and an incubation period of 30 minutes in the dark. 2 µL of 
LysC (.2µg/µl) was added to the sample which and incubated at 37°C overnight with 
shaking at 900 rpm. 600 µL of 100 mM Tris buffer was added to the sample, followed by 
4 µL of 1 M CaCl2. 10 µL of Trypsin Gold (.1µg/µl)) was added to the sample and 





Rtr1 Regulates Premature Transcription Termination 
The production of mRNA is very well studied and uses many complexes of 
proteins to make a stable transcript that will go on to be translated. However, ncRNA is 
more difficult to study and there is more limited knowledge of how it is regulated through 
RNAPII. In this study, I discovered a possible role for Rtr1 in the regulation of both 
ncRNA and mRNA production. I used an RTR1 knockout yeast train to study the effects 
of Rtr1 on RNAPII transcription as well as the changes in interactions that it causes in the 
transcription machinery. My studies provide evidence that premature termination occurs 
in RTR1 knockout cells through the NNS complex subunits Nrd1 and Nab3. I also used 
an RTR1 RRP6 double knockout strain to compare the rtr1Δ cells in order to isolate 
specific changes in the mechanism that do not involve RNA degradation. This work 
suggests that one of the functions of Rtr1 in the cell is to promote elongation and that it is 
a negative regulator of the NNS termination pathway.  
 
1. RTR1 Deletion Results in Changes in PPI Network of Termination Factors   
Phosphorylation of RNAPII CTD is an important regulatory mechanism through 
which transcription termination is directed [237, 367-369]. Deletion of RTR1 leads to a 
global increase in the phosphorylation of Ser-5 of the CTD, and previous studies have 
shown that loss of RTR1 results in 3’-end processing defects at the polyA-dependent gene 
NRD1 [203]. In order to determine the overall role of Rtr1 and how it might regulate 
RNAPII and its PPIs, I performed a DisCo network analysis. For this analysis I used 
affinity purification mass spectrometry (AP-MS), where a tagged protein is purified along 
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with interacting proteins and identify the interacting partners with a mass spectrometer, 
with different strains, including Nrd1-TAP, Pcf11-TAP, and Ssu72-FLAG, in 
combination with the RTR1 deletion to assess the effect of Rtr1 on different facets of 
transcription. DisCo utilizes AP-MS to analyze genetic perturbations to get more in depth 
and large-scale analysis of the cell and understanding of the mechanisms involved. It is 
possible that small changes in specific genes have an effect on PPI networks at non-
primary interactions. In this study, I used SAINT probability scores from yeast cells with 
an RTR1 deletion to create a protein-protein interaction network [357, 358]. This 
experiment resulted in a large data array consisting of 24 x 3,960 protein-level 
measurements from 668,969 peptide-spectrum matches. In order to gain a more realistic 
understanding of the effect of the mutation, I used high-confidence interactions in the 
termination factor complexes as well as Rpb1 and Rpb2 of the RNAPII complex.  
Purifications of Nrd1-TAP, Pcf11-TAP, and Ssu72-FLAG in WT and RTR1 
deletion genotypes were performed and analyzed using prey-prey correlation analysis. 
Proteins with high correlation values have a similar pattern of PSMs across different sets 
of purifications whether or not the same bait protein is used for the purification. This is 
especially true with proteins that act together in the same protein complex or mechanism 
and often have the highest correlation values (Figure 7A). My data show that there is an 
association between all of the CF1A members and CPF members Fip1 and Pap1. The 
CPF members are components of the poly(A) polymerase module, and this association 
reveals that there is a cross-association between CF1A and the CPF complex specifically 
with the poly(A) polymerase module. (Figure 7A) [370]. In addition to the DisCo 
analysis, I also used SAINT to look at individual purifications of the RTR1 deletion 
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versus WT with different tagged proteins Ssu72, Nrd1 and Pcf11. Both the DisCo results 
and the SAINT results reveal that there is an association between CPF and CF1A and that 
Rtr1 may regulate some of these interactions (Figure 7C). The data supports a previous 
hypothesis that linked the CID of Pcf11 to the formation of a CPF/CF1A/RNAPII 
complex necessary to form a stable RNAPII complex at the 3’ end of the gene during 
mRNA polyadenylation [371]. This is evident in the DisCo data when comparing the WT 
to the RTR1 deletion strain. Loss of Rtr1 results in a significantly decreased, if not 
eliminated, association between the CF1A complex proteins and the CPF members 
(Figure 7B). These data also show a reduction in the correlation between CF1A and 
RNAPII subunits Rpb1/2. As SAINT analysis contains a probability algorithm, additional 
information can be gained about the protein interactions among the termination 
machinery or transcription proteins. Ssu72 is a phosphatase and an essential member of 
the CPF complex. All CPF subunits had SAINT probabilities of ≥ 0.95 (Figure 7C). This 
is consistent with previous work from the Mosley lab showing that SAINT probability 
scores of ~0.95-1 are indicative of proteins within the same complex. The SAINT scores 
for proteins that are not in complex with the bait protein can vary greatly depending on 
the degree to which they interact with the bait. This variation can be decreased through 
replicate experiments and by increasing specificity. Data from the Mosley lab has shown 
that proteins known to interact with RNAPII in a more dynamic fashion can have a range 
of SAINT probabilities, for example 0.23 for Spt16 or 1 for Spt5, Pta1, Tfg1, and Tfg2, 
in replicate Rpb3-TAP purifications [372]. Without prior knowledge of a known PPI, a 
low interaction score would reveal that this interaction does not have a high probability of 
being a true interaction. However, it is possible that the interaction is not always present 
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in the cell or is not always detectable for a variety of reasons including stability, low 
affinity or heterogeneity of the interactions in a complex or in the cell. In the Ssu72-
FLAG purifications, the two largest subunits of RNAPII, Rpb1 and Rpb2, were identified 
as significant interacting proteins with Ssu72 in WT and rtr1Δ cells while rtr1Δ cells had 
a significant interaction between Ssu72 and Rpb3 (Figure 7C). Rpb1 and Rpb2 are the 
largest proteins in the RNAPII complex and contain the most detectable peptides amongst 
the twelve RNAPII subunits and therefore the highest probability of detection when using 
AP-MS [355]. These data show that the loss of Rtr1 leads to a change in the interactions 
in the other serine-5 phosphatase Ssu72 and its complex with RNAPII specifically by 
increasing CPF interactions with Rpb1 and Rpb2 (Figure 7).  
SAINT analysis of the CF1A tagged protein Pcf11-TAP and Pcf11-FLAG 
purifications from WT and RTR1 deletion cells (n ≥ 4) detected the four protein members 
of CF1A with probabilities ≥ 0.95, which supports their designation as a protein complex 
(Figure 7C). Previous studies have shown that the purified Pcf11 CID domain has lower 
affinity for Ser5-P and Ser2,5-P than Ser2-P modified CTD [371]. The Mosley lab has 
shown, using ChIP assays with antibodies specific for S2P and S5P, that Ser2/5 is less 
phosphorylated on genes globally as a result of RTR1 deletion in the cell and histone 
H3K36me3 levels are increased which would be expected with less Ser2/5 
phosphorylation [373]. In WT cells, Rpb1 and Rpb2 have a high SAINT probability for 
interacting with Pcf11. In the RTR1 deletion cells the interaction between the RNAPII 
subunits and Pcf11 disappears statistically in both the SAINT analysis and the prey-prey 
correlation analysis (Figure 7).   
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Figure 7: DisCo network analysis of RNAPII transcription in WT and rtr1Δ cells in yeast. 
(A) Prey-prey correlation analysis of the termination complex AP-MS data from WT 
cells of ≥ 4 biological replicate purifications for bait proteins (Nrd1, Pcf11, and Ssu72, 
total n=12). (B) Prey-prey correlation analysis of yeast termination complex AP-MS data 
from rtr1Δ cells of ≥ 4 biological replicate purifications for each bait protein (Nrd1, 
Pcf11, and Ssu72, total n=12). (C) Ssu72-FLAG, Pcf11-TAP and Pcf11-FLAG, and 
Nrd1-TAP protein-protein interaction networks from WT and rtr1Δ cells depicting 
SAINT analysis of ≥ 4 biological replicate purifications for each genotype. The nodes 
represent a protein of interest whereas the edges represent the SAINT interaction 



























































































































































































Although the data show that there are no interactions between Pcf11 and Rpb1, it is still a 
plausible interaction, but it is below the detection limit in this particular AP-MS study.  
Many of the CPF subunits were found in the AP-MS study using the Pcf11-FLAG 
at low levels and were more apparent in the SAINT analysis relative to the correlation 
analysis. Of interest, in the RTR1 deletion cells, the PPI SAINT scores for CPF proteins 
in the CF1A Pcf11-FLAG purification was not increased nor decreased relative to the 
WT purifications but did have less CPF subunits (Figure 7C). Thus, it is possible that 
CF1A still interacts with the CPF subunits, even with a decrease of Pcf11 and RNAPII 
interactions, due to the loss of Rtr1. It is likely that the interactions between CPF and 
CF1A are maintained due to their role in regulating nascent RNA and are stabilized 
through their interactions with a phosphorylated RNAPII CTD in a WT cell.  
Nrd1 has been reported to function in complex within both the NNS complex 
(Nab3, Sen1) and the with capping complex proteins Cbc2, and Sto1 [374]. My AP-MS 
SAINT analysis of an Nrd1-TAP tagged protein does not support this theory. Only the 
Nab3 protein co-purified with Nrd1 well enough to have high SAINT scores of ≥ 0.95, a 
result consistent with the pre-prey correlation analysis (Figure 7). Although Sen1, Sto1, 
and Cbc2 were identified as Nrd1 interacting proteins, their SAINT probability values 
resemble those of dynamic or low affinity interacting partners of the bait Nrd1 and not of 
proteins that would be in complex with Nrd1 (Figure 7C). In addition, subunits of the 
TRAMP complex and the nuclear exosome were detected as dynamic interacting partners 
of Nrd1 determined by SAINT analysis, consistent with work from the Buratowski lab 
(Figure 7C)  [374]. Previous work has shown that the Nrd1 CID has the highest affinity 
for Ser5-P and Ser2,5-P CTD repeats and the abundance of these phosphorylations are 
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increased in RTR1 deletion mutants [203, 368, 373]. Nrd1 also had an interaction with 
Rpb1 and was identified with a SAINT score of 0.49 in rtr1Δ cells. Taken altogether 
these data show that loss of Rtr1 increases the interaction between Nrd1/Nab3 
heterodimer and RNAPII in vivo. This is most likely due to the increase in 
phosphorylation of serine 5 of the CTD. In RTR1 deletion cells the probability score of 
the interaction between Rpb1 and Nrd1 was lower that what was calculated for Pcf11 
from WT cells. Thus, it is possible that the interaction of Rpb1 and Nrd1 occurs, but at a 
lower frequency than the interaction between Rpb1 and Pcf11.  
 
2. Rtr1 Regulation of ncRNA Gene Expression 
In order to analyze how the transcriptome changed after loss of the S5P 
phosphatase Rtr1, I performed strand-specific RNA-seq of total RNA in a set of four 
biological replicates. Since it was expected that RTR1 deletion would have a global effect 
on transcription, this experiment required an external standard, such as a spike-in of a 
known quantity of RNA, to be able to measure the changes in the transcriptome [375]. 
RNA reads were aligned and then analyzed for differential expression using the edgeR 
package (Figure 8) [362]). In order to identify differential expression of certain classes of 
genes such as sn/snoRNAs, ORF-Ts, CUTs, SUTs, SRTs and NUTs, I used annotations 
that were previously described from work from several labs [13, 160, 376]. I also used 
annotations from previous work from the Mosley lab where RNAs that are antisense to 
ORF-Ts are labeled as ASTs [377]. In this study 1481 out of 11,151 transcripts were 
reduced in rtr1Δ cells, many of which were ASTs as well as other ncRNA (Figure 8A/B).  
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Figure 8: Loss of Rtr1 activity leads to global differential expression changes in ncRNA 
in yeast. (A) Volcano plot of normalized RNA-Seq data for protein coding genes and 
non-protein coding genes in RTR1 deletion vs. WT cells (n=4, edgeR analysis). Data 
includes all annotated ORF-Ts cryptic unstable transcripts (CUTs), Nrd1 unterminated 
transcripts (NUTs), SNR extended transcripts, Ssu72 restricted transcripts (SRTs), and 
antisense transcripts (ASTs). False discovery rate (FDR) cutoff of ≤ 0.05 is apparent with 
a dashed red line. Plots also show the quantity of genes that correspond to the number of 
genes that are at each axis for comparison. (B&C) Pie charts of transcripts differentially 
expressed in rtr1Δ cells relative to WT cells across different RNA transcript classes. 
Downregulated transcripts are shown in the red diagram while upregulated transcripts are 
shown in the green diagram.  
 
Fewer transcripts were upregulated, 276 were increased more than 1.5-fold, most of 
which were ORF genes (Figure 8C). Of note, the IMD2 gene had the biggest reduction of 
expression while its upstream CUT was also significantly reduced. This gene is well 
described and is known to be regulated by the NNS termination pathway through an NNS 
terminator signal, but is also regulated by GTP levels in the cell (Figure 8A, labeled in 
green) [242, 351, 378-380]). My data interestingly show that somehow Rtr1 is helping to 
regulate both of the IMD2 and IMD2 CUT genes possibly independently through the 
NNS pathway. 
 Overall, the data show that loss of Rtr1 phosphatase activity results in the 
downregulation of different classes of ncRNAs and also has an effect on specific mRNA 
genes. It is possible that the increased levels of Serine 5 phosphorylation on the CTD of 
RNAPII in the RTR1 deletion cells may cause increased activity and/or efficiency of the 
NNS termination mechanism. Increasing the efficiency of the NNS mechanism would 





3. RNAPII and Nrd1 Occupancy are Reduced at SNR Genes in rtr1Δ Cells 
Analysis of total RNA in the RTR1 deletion cells revealed that many ncRNA 
classes had a reduced expression including SNR genes (Figure 8). SNR extended 
transcripts (ETs) in particular, which are genes that have been shown to transcribe past 
their termination site when termination is defective, had a lot of differential expression 
[381]. SNR transcripts generally need to be processed at their 3’ end by NNS termination 
in conjunction with the TRAMP complex and finally the RNA exosome [374, 381-386]. I 
performed an average gene analysis using ChIP-exo datasets for both Rpb3 and Nrd1 for 
the SNR genes aligned to the TSS with 500 bp upstream and 1000 bp downstream of the 
TSS [365]. The average RNAPII occupancy at SNR genes was decreased in RTR1 
deletion cells (Figure 9A). The Nrd1 signal at the SNR genes was also decreased. In 
addition, Nrd1 levels decreased to a greater degree than Rpb1 proportionally, which 
might suggest that lower levels of Nrd1 are necessary for termination in cells without 
Rtr1 or that efficiency of Nrd1 has increased as a result of the deletion of RTR1. Also, the 
reduction of RNAPII levels at SNR genes could mean that loss of Rtr1 may be affecting 
total RNAPII that are undergoing transcription by increasing the speed of termination 
(Figure 9). This hypothesis is bolstered further by the data that show that the SNR-ETs 
are decreased in the RTR1 deletion cells (Figure 9B). This could suggest that termination 
is occurring earlier than normal at these SNR genes due to the lack of Rtr1. The argument 
could be made that overall transcription for the SNR genes is reduced. However, my data 
show that this is not the case since several mature SNR transcripts including snR62, 
snR32 snR189 and snR46 are not statistically any different in the rtr1Δ cells vs the WT 
cells which would mean that the effects are only occurring at the 3’ end of the genes.  
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Figure 9: Loss of Rtr1 phosphatase activity leads to decreased RNAPII signal at SNR 
genes and leads to shortened SNR transcripts. (A) Average gene analysis of RNAPII and 
Nrd1 signal at SNR genes in WT or RTR1 deletion cells. The vertical axis values are 
average read counts per million (RPM) values calculated using ngs.plot -500 and +1000 
nucleotides relative to the SNR gene annotated TSSs in either WT or RTR1 deletion cells. 
(B) RNA-Seq read counts for manually annotated SNR-ET regions from a subset of SNR 
genes.  
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4. Global Levels of RNAPII and Nrd1 Occupancy are Transformed in rtr1Δ 
Cells  
Nrd1 localization is highest at genes transcribed by RNAPII that contain the RNA 
binding motif for Nrd1 and Nab3, such as the URA8 gene. Others have previously shown 
that Nrd1 accumulates on the gene downstream of the peak of serine 5 phosphorylation of 
the RNAPII CTD of protein coding genes, a result which I have also replicated in this 
study [149, 151]. In contrast, protein-coding gene PMA1 RNAPII occupancy is similar 
across the entire gene, but Nrd1 localization is higher at the 5’ end of the gene ~270-321 
bp past PMA1s transcription start site (data not shown). In order to see the effect that Rtr1 
has on RNAPII and Nrd1 localization, I compared the average occupancy of Nrd1-TAP 
and Rpb3-FLAG at 2426 protein coding genes looking at a window that starts at 200 bp 
upstream of the genes TSS and 1000 bp downstream of the TSS and overlaid the data to 
average histone occupancy data in WT cells from an MNase-Seq experiment(Figure 10). 
In addition, I plotted the same data at a different window of 200bp upstream of the TES 
and 200bp downstream of the TES. Occupancy of Rpb3 was higher at the 5’ end of the 
genes in the rtr1Δ cells compared to the WT. In contrast Rpb3 localization decreases in 
the rtr1Δ cells more than in the WT cells at the 3’ end of the protein coding genes as well 
as at the TES (Figure 10A). Nrd1 occupancy also displayed decreased occupancy at the 
3’ end of the gene in the rtr1Δ strains relative to WT (Figure 10B). In addition, the ratio 
of RNAPII occupancy at the TSS relative to the TES at genes of varying occupancy 
levels further displays that deletion of RTR1 leads to a decrease in RNAPII occupancy at 
the TES (Figure 10C). When the Rpb3-FLAG and Nrd1-TAP ChIP-exo average global   
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Figure 10: RTR1 deletion leads to decreases RNAPII occupancy at the transcription 
termination site of protein-coding genes. Average protein coding gene analysis of 
RNAPII (Rpb3) (A) or Nrd1 (B) levels at 2,426 protein-coding genes -200 bps upstream 
and +1000 downstream of the TSS and -200/+200 upstream/downstream of the TES. The 
data on the vertical axis is average RPM values calculated using ngs.plot for each 
genotype designated by the colors in the legend. (C) Log ratio of RNAPII occupancy at 




data at protein coding genes are overlaid on each other it is clear that the RNAPII 
occupancy begins to decrease just after Nrd1’s highest localization peak (Figure 11). 
IMD2 is a well-studied gene that has an upstream CUT transcript. The IMD2 CUT 
gene is terminated by the NNS pathway but is usually transcribed and decreases the 
levels of IMD2 mRNA. IMD2 mRNA levels are low while levels of the guanine 
nucleotide are high, but when the guanine levels are low IMD2 CUT is terminated early 
due to the fact that an alternative TSS is used and IMD2 mRNA levels increase in the cell 
to produce more guanine (Figure 12A). As these cells were grown in YPD, there was 
sufficient guanine so that IMD2 CUT should be produced at an earlier TSS and 
terminated at the intergenic terminator by the NNS termination pathway (Figure 12A). 
When guanine is low the TSS that RNAPII utilizes is within the intergenic terminator. 
(Jenks Reines 2008). Using ChIP-exo, one can analyze RNAPII and Nrd1 localization, 
the results showing that both RNAPII and Nrd1 mapped to the upstream region of IMD2 
at the CUT region with low levels of RNAPII localized at the protein coding region in 
WT cells (Figure 12B/C). In rtr1Δ cells, both Nrd1 and RNAPII levels were reduced just 
as the SNR genes were reduced (Figure 12B/C). Additionally, I performed RNA-seq 
analysis of rrp6Δ and rtr1Δ rrp6Δ cells in order to analyze the role that the RNA 
exosome might have on ncRNA in cells lacking Rtr1 (Figure 13A/B).   
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Figure 11: Gene average profiles of ChIP-exo occupancy for RNAPII (Rpb3) and Nrd1 in 
WT and RTR1 knockout cells. The legend displays the color for each sample. MNase-




Figure 12: Rtr1 is required for basal IMD2 expression. (A) Schematic representation of 
NNS-dependent attenuation of the IMD2 gene. Arrows designate alternative start sites. 
Occupancy of RNAPII (B) and Nrd1 (C) at the IMD2 gene. Data derived from WT cells 
is in black, and those from the rtr1Δ strain are in orange. The location and direction of 
transcription for all analyzed annotations are diagrammed below the graphs, each to 
scale. Red dashed line represents TSS of IMD2. D) Expression of the IMD2 mRNA 
RNA-Seq (n=4). E) Expression of IMD2 upstream CUT by RNA-Seq (n=4). F) Northern 







































































































Figure 13: Volcano plots in RRP6 and RRP6 RTR1 knockout transcriptomes relative to 
WT. Density plots are on the right and illustrate the number of points in each area as 
indicated. The number of decreased and increased transcripts based on a fold-change 
cutoff of 1.5-fold and an FDR of at least 0.05 are shown at the top of each panel for 
rrp6Δ (A) and rrp6Δ rtr1Δ (B) [387].  
 
Previous studies have shown that by deleting RRP6 the upstream IMD2 CUT is 
increased, which my results confirmed, although the CUT was decreased in the rtr1Δ 
strain (Figure 12) (Davis Ares 2006 and Steinmetz Brow 2006). The rtr1Δ rrp6Δ cells 
maintained steady levels of the upstream IMD2 CUT relative to WT indicating that the 
RNA exosome might be degrading the CUT RNA following NNS termination in cells 
lacking Rtr1. It is also possible that there could be change in the elongation mechanism 
that could have had an effect on the differential levels of the CUT RNA in the rtr1Δ and 
rtr1Δ/rrp6Δ cells. Interestingly, the results show that the IMD2 coding region is altered in 
the rtr1Δ probably because it is close to the Nrd1/Nab3 binding sites of the IMD2 TSS 
(Figure 12B/C). IMD2 mRNA expression decreased 5-fold in rtr1Δ cells and when RRP6 
was deleted alone there was no statistically significant change (Figure 12D). However, 
when both RTR1 and RRP6 were deleted, IMD2 mRNA levels did decrease relative to 
WT, but not quite to the same extent as with the RTR1 deletion alone. In order to analyze 
the full-length transcripts that were produced in the cell, I performed Northern blots. The 
Northern blot analysis of IMD2’s coding region revealed similar results as the RNA-seq 
data at the coding region (Figure 12F). The data also confirmed that a mutant version of 
another serine-5 phosphatase, Ssu72-tov, displayed termination defects, which resulted in 
elevated expression levels of IMD2 [350]). These data suggest that Rtr1 may be acting as 
a negative regulator of NNS termination, compared to the Ssu72 and Rrp6 mutants which 
seem to decrease the NNS termination pathway efficiency.  
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5. Rtr1 Promotes Elongation of ASTs 
The loss of Rrp6 in the rtr1Δ strain did not lead to full recovery of IMD2 RNA 
levels as compared to the loss of Rrp6 in WT which had no effect. This suggests that Rtr1 
may promote elongation of ncRNA in WT cells, and the change in RNA expression due 
to the loss of Rtr1 is not a change in stability of RNA but is an effect of Rtr1 attenuating 
or decreasing the efficiency of the NNS termination pathway. In order to confirm this 
hypothesis, I analyzed and compared global RNA-seq of both the rrp6Δ and rtr1Δ rrp6Δ 
transcriptomes relative to WT (Figure 13). When analyzing 104 ASTs that were 
significantly downregulated in rtr1Δ cells, I found that most of the Rtr1 regulated ASTs 
were dependent on the RNA exosome for the decreased expression of the ASTs (Figure 
14). It is possible that the decrease in expression of the ASTs in the cells missing Rtr1 is 
related to increased premature ncRNA termination through the NNS pathway and 
requires the RNA exosome for degradation [383]. Previous research has shown that 
RNAPII elongation of ncRNA including ASTs can regulate the RNA expression of 
protein coding genes in what is called transcription interference [246]. Thus, it is possible 
that the increase in ncRNA elongation stimulated by Rtr1 in WT cells may be changing 





























Cluster:     I              II          III           IV        
78 
Figure 14: WT, rtr1Δ and or rrp6Δ strains differentially expressed genes. Heat map of 
transcripts that were differentially expressed in rtr1Δ, rrp6Δ, and rtr1Δ rrp6Δ strains 
relative to WT cells. Scale at the right displays read count of each gene. Unsupervised 
hierarchical clustering analysis was performed using normalized read count values for 
each biological replicate and genotype (n=16). Each genotype shows all the biological 
replicates clustered together illustrating a high degree of reproducibility between 
replicates with WT values groups as Cluster IV, rtr1Δ values grouped as Cluster III, 
rtr1Δ rrp6Δ grouped as Cluster II, and rrp6Δ grouped as Cluster I.    
 
Past studies have shown that transcription of the mRNA gene YKL151C is 
regulated by an antisense transcript, YKL151C AS , which is terminated by the NNS 
termination pathway (Creamer Corden 2011). This transcription interference of YKL151C 
by its antisense gene is modeled in Figure 15A. To confirm the RNA-seq results and to 
analyze the full-length RNA of the YKL151C / YKL151C AS genes, I performed Northern 
blot analysis using single-stranded RNA probes. The data show that the YKL151C sense 
transcripts are up-regulated in the rtr1Δ cells, a result possibly caused by YKL151C AS 
transcript downregulation (Figure 15B). The Northern data show an opposite effect in the 
RRP6, and rrp6Δ/rtr1Δ cells, which could be caused by decreased NNS termination 
leading to higher expression of sense YKL151C (Figure 15). In addition, the cells with the 
termination deficient Ssu72 mutation had decreased expression of sense YKL151C while 
its AST showed an increase in expression (Figure 15B). Finally, the RNA-seq analysis 
verified that YKL151C sense is upregulated in rtr1Δ cells while the AS YKL151C 





Figure 15: Analysis of YKL151C sense and antisense expression in WT and rtr1Δ cells. 
(A) Schematic representation of YKL151C sense and antisense expression. (B) Northern 
blot analysis of YKL151C sense and antisense transcripts using single-stranded RNA 
probes. (C) and (D) Summary of RNA-Seq expression analysis of YKL151C sense and 

















































































































Ssu72-L84F Mutant Results in Change in Transcription Termination Mechanism 
Ssu72 is an essential gene so that previous studies have focused on Ssu72 
mutations causing diminished function [296]. The first SSU72 mutant described consisted 
of a duplication of amino acids 9-18 together with another mutation, which conferred a 
heat sensitive phenotype and shifted transcription start sites of select genes [296]. In the 
same study, it was discovered that Ssu72-C15S was lethal, and C15 was later confirmed 
to be a residue necessary for dephosphorylation activity [276, 296]. Relative to 
transcription termination, many studies have found that loss of function mutations or the 
depletion of Ssu72 leads to increased gene expression or modest read-through of 
termination sites [184, 185, 276, 277, 388, 389]. In this study, I focus on an Ssu72-L84F 
mutant yeast strain in which RNAPII has been shown to transcribe or read-through a 
termination signal upstream of the IMD2 ORF (Figure 16) [350]. My goal was to 
investigate the effect of the Ssu72-L84F mutant on termination sites by analyzing 
RNAPII localization globally, through high resolution ChIP-exo, and by measuring 
transcript length and quantity through RNA sequencing and Northern blot analysis. My 
results show that the L84 residue of Ssu72 is important in regulating phosphatase activity 
and the mutation of L84 to F confers a gain of function that increases the phosphatase 
activity of Ssu72. In addition, the Ssu72-L84F mutation leads to increased RNAPII 
occupancy downstream of transcription termination sites as well as increased RNA 




Figure 16: Spontaneous mutant Ssu72-L84F can bypass an intergenic terminator. 





1. Ssu72-L84F Mutation Confers Gain of Function Phenotype 
To investigate if the L84F mutation affected activity of the Ssu72 phosphatase, a 
Western blot was performed on yeast whole cell lysate with antibodies specific to several 
forms of the phosphorylated CTD as well as an antibody specific to the CTD itself. WT 
BY4742 and Ssu72-L84F strains were used, both had a 3XFLAG tag on the Rpb3 subunit 
of the RNAPII complex to initially measure CTD phosphorylation. Initial results in two 
independently isolated clones found a decrease in signal in the serine-5 phosphorylated 
CTD as well as the serine-7 phosphorylated form of the CTD relative to the WT (Figure 
17A). This result suggests that Ssu72-L84F is a hyperactive mutant, which is surprising, 
since previous Ssu72 mutants that caused read-through were loss of function mutants 
[184, 185, 276, 277, 388, 389]. In addition, the RNAPII subunit Rpb3 levels were 
unchanged in the mutant strain compared to WT, and the cytosolic protein Pgk1 show 
consistent loading across all of the samples. Taken together this suggests that the L84F 
mutation in Ssu72 decreases serine 5 and serine 7 phosphorylation of the RNAPII CTD. 
To further confirm these results, yeast strains were generated expressing Rpb3-3XFLAG 
in both WT and Ssu72-L84F strains with a 3C cleavage site inserted within the linker 
region of the CTD, before the repeating heptad sequence begins. RNAPII was 
immunocaptured through the Rpb3-3X FLAG tag on anti-FLAG antibody beads and 
while immobilized the CTD was released through 3C protease treatment and 
subsequently collected with the flow through material.  CTD phosphorylation levels were 
measured using antibodies specific to Ser2-P CTD, Ser5-P CTD, Ser7-P CTD. Total 
CTD was used as a loading control and detected using a commercially raised antibody 
directed against the N-terminal portion of the CTD fragment that is released following 3C 
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protease cleavage in the strains. Surprisingly, phosphorylation was reduced in the Ssu72-
L84F mutant compared to the WT at all three serine residues suggesting that Ssu72-L84F 
is a hyperactive variant that has lost specificity for serine 5 and serine 7 alone (Figure 
17B). Additionally, the CTD migrated faster through the gel in the Ssu72-L84F mutant 
compared to the WT, suggesting an overall decrease in the bulk phosphorylation status of 
the CTD (Figure 17B). This change in CTD dephosphorylation activity could occur as a 
consequence of changes in CTD binding affinity and/or a change in phosphatase activity.  
In order to look at the specific activity of the mutant phosphatase, a phosphatase activity 
assay was performed with different mutants of Ssu72, at 2 µΜ (concentration determined 
by Bradford protein assay), including the catalytically inactive C15S, the WT, the Ssu72-
L84F mutant, and the L84A mutant using a small molecule substrate. Using 10 µΜ 
DiFMUP (6,8-Difluoro-4-Methylumbelliferyl Phosphate)) as a substrate, the Ssu72-L84F 
mutant has significantly increased phosphatase activity relative to WT and the Ssu72-
L84A mutant had even greater phosphatase activity than the Ssu72-L84F mutant (Figure 
17C). 
 
2. Global Changes in the Transcriptome  
Ssu72 is an essential gene that plays a role in many transcriptional mechanisms and 
thus I  hypothesized that the Ssu72-L84F mutant, which disrupts the termination 
mechanism of the IMD2 terminator, would have a large effect on the transcriptome as a 
whole [350]. RNA-seq was performed to investigate any changes in the transcriptome in 
the Ssu72-L84F mutant compared to WT cells.   
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Figure 17: L84F mutation in Ssu72 affects phosphatase activity. (A) Western blot of 
whole cell lysate in WT and Ssu72-L84F strains. Antibodies specific for serine 5 
phosphorylated CTD, serine 7 phosphorylated CTD, and loading controls RNAPII(Rpb3-
FLAG) and PGK1. (B) Western blot on CTD from WT and Ssu72-L84F strains. 
Antibodies specific for serine 5 phosphorylated CTD, serine 7 phosphorylated CTD, 
serine 2 phosphorylated CTD, the CTD fragment itself and control RNAPII(Rpb3-
FLAG). (C) Phosphatase activity assay using substrate DifMUP. Relative fluorescence 
was measured after 120 minutes at 450nm. C15S renders phosphatase inactive and 
abolishes cell viability. L84A and independently transformed L84A-2 mutants were 
created in the Mosley lab. Phosphatase activity assay using purified GST protein yielded 
results similar to C15S (data not shown)  
Pgk1
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To control for a large change in the transcriptome that could occur as a consequence of 
disruption of a central basal transcription regulator, I utilized a spike-in control (ERCC, 
Invitrogen) for a more accurate normalization of the RNA expression data. Considering 
that Ssu72 is involved in the CPF pathway and has previously been implicated in the 
generation of novel noncoding RNAs (ncRNAs), total RNA sequencing was performed, 
and a number of noncoding RNA transcripts annotations were included in the alignment 
steps. In brief, many regions of DNA previously thought to be transcriptionally inactive 
have been observed to be undergoing pervasive transcription [12, 156-158]. In addition, 
there is evidence that a major source of pervasive transcription occurs at bi-directional 
promoters and at nucleosome depleted regions (NFRs), resulting in a plethora of ncRNAs 
such as: stable unannotated transcripts (SUTs), cryptic unstable transcripts (CUTs), Nrd1 
unterminated transcripts (NUTs)  and Ssu72 restricted transcripts (SRTs) [12, 13, 159, 
160]. The function and purpose of many of these emerging ncRNA classes are yet to be 
completely understood. Most small ncRNAs, including sno/snRNAs are terminated via 
the Nrd1-Nab3-Sen1 (NNS) termination pathway in Saccharomyces cerevisiae which 
generally leads to non-coding transcripts being either degraded or processed [12, 130, 
137, 147, 148, 159, 165, 237, 244, 250].  
Our results combined RNA-seq data from four biological replicates and compared 
11,296 annotations (including 5,794 ORF-Ts, 2,640 AST’s, 1,157 NUTs, 711 SUTs, 434 
CUTs, 214 SRTs, 80 snRNAs and 78 snRNA extended transcripts snRNA-ETs) (Figure 
18A). Overall, there was a distinct trend of RNA overexpression genome-wide in the 
Ssu72-L84F strain relative to the WT (Figure 18A). A total of 3,232 transcripts, out of 
11,296, were overexpressed and 755 transcripts had decreased expression (at an FDR less 
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than or equal to 0.1) which means that overall there was six fold more genes that were 
overexpressed. A number of mRNAs were significantly affected by the L84F mutation as 
15% of the 5,794 annotations analyzed were differentially expressed (FDR < 0.1 Figure 
18B). Non-coding RNAs were strongly affected by the Ssu72-L84F mutation, differential 
expression for each transcript class specifically was; snRNA-ET 71%, CUTs 60%, SRTs 
58%, NUTs 56%, SUTs 45%, snRNAs 40%, and ASTs 34% (Figure 18B). Surprisingly, 
the differential expression profile for Ssu72-regulated transcripts (SRTs) in the Ssu72-
L84F mutant was significantly different than that of another Ssu72 mutant (Ssu72- 
R129A), which also affected ncRNA transcription, indicating that each mutation acts in a 
distinct manner (Figure 19A). Of note, many of the Ssu72-R129A regulated SRTs were 
upregulated in rrp6Δ cells (n=105) and of those transcripts there was a high-degree of 
overlap with Ssu72-L84F (Figure 19B). These data suggest that the Rrp6-containing 
nuclear exosome may be involved in the regulation of many of the SRTs that are 
upregulated in Ssu72-L84F cells. This is consistent with previously described increases in 
SRT detection in Ssu72-R129A rrp6Δ double mutant cells [13].  Although Rtr1 and 
Ssu72 have both been characterized as CTD phosphatases, it is of note that rtr1Δ cells, 
only a small number of SRTs were up-regulated (n=7, data not shown) and instead more 





Figure 18: Differential expression analysis of whole transcriptome sequencing performed 
with ERCC spike-in controls for normalization. (A) Volcano plot illustrating Ssu72-L84F 
differential expression [-log10 FDR (y-axis) and fold-change (x axis)]. (B) Overview of 
transcript categories with varying degrees of differential expression changes in Ssu72-







































Figure 19: Differential expression analysis comparison of Ssu72-L84F strain and Ssu72-
R129A strain. (A) Plot comparing the differential expression of annotated SRTs in the 
ssu72-TOV strain and ssu72-2 strain. Gene expression of all annotated SRTs of the 
different strains were divided by WT expression and then the ratio of the fold change was 
converted to log of 2. Values for each strain were plotted relative to each other Ssu72-
L84F on the y-axis and Ssu72-R129A on the x-axis. (B) Venn diagram comparing the 
different trains and the SRTs. 
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microarray, Tan-Wong, 2012)
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Finally, snRNA-extended transcripts (ETs, annotations of snRNAs that are 
downstream of the snRNA termination points, [248]) showed the largest percentage of 
differential expression for any gene category at 71% when compared to the 40% of 
snRNA transcripts, which provides evidence that the Ssu72-L84F mutant is causing read-
through termination defects in these genes (Figure 18B). rtr1Δ cells showed the opposite 
phenotype to Ssu72-L84F cells for extended transcripts with more frequent decreases in 
snRNA ETs.  
 To gain a better understanding of how individual genes were affected, read counts 
per nucleotide at different genomic location which contained an snRNA gene were 
analyzed. Additionally, differential expression analysis revealed some downstream effect 
of snRNA gene readthrough because 85% of sn/snoRNA genes have an mRNA gene at 
least 500 nucleotides downstream of the snRNA termination site and in some cases the 
downstream gene was upregulated likely as a consequence of transcription readthrough. 
In the Ssu72-L84F mutant strain, snR82 displayed a slight decrease in expression 
throughout the body of the gene, but at the 3’ end near the termination site there was 
significantly more expression relative to the WT (Figure 20A). This trend continued 
through the mRNA gene USE1 downstream of the snoRNA gene snR82. In order to 
verify that the increased RNA detected at USE1 was indeed a consequence of read-
through of the snoRNA terminator, Northern blot analysis was done. I used a radioactive 
probe specific to the transcript from within the body of the snR82 gene. The Ssu72-L84F 
mutant produced a transcript that in addition to the normal length of the snR82 transcript 
(268 bp) was ~1,800 nucleotides long, which is about the length from the beginning of 
the snR82 gene to the end of the USE1 gene (Figure 20B).   
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Figure 20: RNA-seq reads and Northern Blots of Ssu72-L84F at snR33 and snR82. 
(A)&(C) RNA sequencing reads at two regions of the genome showing the effects of the 
Ssu72-L84F mutant on gene expression at region around snR82 and snR33. Ssu72-L84F 
has increased gene expression downstream of the snRNA termination sites. (B)&(D) 
Northern blots showcasing the increased length of the ncRNA due to read-through. 
Northern blot with oligonucleotide specific to snR71. The Ssu72-L84F mutant has an 






The WT strain only expressed transcripts of a single length of ~180 nucleotides. In this 
Northern I also analyzed an rrp6Δ strain which displayed two groups of transcripts, the 
normal length snRNA and a slightly longer transcript (~500 nucleotides) which 
represents the unprocessed snR82 transcripts. The Ssu72-L84F strain did not have the 
extra group of transcripts created in the rrp6Δ strain indicating that the effect of Ssu72-
L84F is not solely occurring through changes in the action of the nuclear exosome. The 
snoRNA snR33 had more RNA expression throughout the gene body in the Ssu72-L84F 
cells relative to the WT, but at the 3’ end and downstream of the termination site there 
was a pronounced increase in RNA production across the CTO1 gene (Figure 20C). The 
Northern blot of the snR33 RNA populations displayed a heterogeneous mix of transcript 
lengths in the Ssu72-L84F strain (Figure 20D). Along with the normal length snR33 
RNA, there was a distinct group of transcripts that spanned the length of the snR33 gene 
as well as the length of the CTO1 gene (~1400 nt), as well as a smear of shorter 
transcripts (~800-1200 nt), and a smaller group of very long transcripts (~3500 nt). 
Again, the slightly longer group of snR33 transcripts (~300 nt), which are likely 
unprocessed forms form of the snoRNA, are observed in the rrp6Δ strain but are not 
present in the Ssu72-L84F strain. In the snR33 RNA Northern blot, an Nrd1 mutant with 
the deletion of the Nab3 interacting domain was also included. Other snoRNAs, such as 
snR71, have also been shown to produce a heterogeneous mixture of unterminated 
transcripts in the Ssu72-L84F strain (also known as Ssu72-TOV [248]) and other mutant 
backgrounds [381].            
 
3. RNAPII Localization Analysis Indicates Termination Read-through 
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To analyze the effects that of mutant phosphatase Ssu72-L84F on RNAPII, I tracked 
the abundance of RNAPII throughout the genome using high-resolution ChIP-exo which 
we have previously employed to track RNAPII termination changes [248]. In this 
experiment, the third largest subunit of RNAPII, Rpb3, was tagged with 3XFLAG in the 
Ssu72-L84F strain at its chromosomal locus. For comparison, the impact of Ssu72-L84F 
on RNAPII occupancy was investigated at the snoRNA genes for snR82 and snR33. 
RNAPII localization was consistent with the changes observed with snR82 RNA 
expression, with RNAPII localized throughout the snR82 gene in both WT and Ssu72-
L84F cells. However only in Ssu72-L84F RNAPII appears to continue downstream of the 
snR82 termination site perhaps accumulating at the TSS of USE1 but also continuing 
downstream into the USE1 gene (Figure 21A). These data suggest that RNAPII reads 
through the snR82 terminator but is eventually terminated at the USE1 termination site, 
likely through a polyA-dependent termination mechanism. Additionally, it is possible that 
the area around the USE1 TSS show RNAPII accumulation as a consequence of 
competition between RNAPII that is continuing to transcribe past the snR82 gene but is 
subsequently competing with the RNAPII that is trying to transcribe the USE1 gene.  
Use1 is an essential protein so it is highly likely that a sufficient amount of Use1 mRNA 
is being produced to maintain its expression. RNAPII showed a similar trend on snR33 
with somewhat lowered accumulation of RNAPII across the 5’ end of the snR33 gene 




Figure 21: RNAPII occupancy of Ssu72-L84F at snR33 and snR82. (A)&(B) Chromatin 
immunoprecipitation and exonuclease analysis (ChIP-exo) of Rpb3-FLAG data at two 
regions of the genome showing the effects of the Ssu72-L84F mutant on the occupancy 
of RNAPII. Localization of RNAPII at region around snR82 and snR33 gene; Ssu72-
L84F has a shifted RNAPII localization downstream of the snRNA termination sites and 
a reduced accumulation of RNAPII at the snRNA genes. 
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EdgeR was used to measure differential RNAPII localization and 594 gene 
annotations showed signs of differential RNAPII localization at an FDR < 0.01 when 
comparing the Ssu72-L84F mutant to the WT with most of the annotations showing 
increased relative RNAPII levels in the Ssu72-L84F mutant, which is in agreement with 
the RNA-Seq dataset (compare Figure 18A and Figure 22). At an FDR < 0.05 a total of 
938 gene annotations showed changes in RNAPII occupancy. Increased RNAPII 
occupancy was measured at a number of snoRNA targets including snR37 as well as 
snR68 which has previously been found to have RNAPII readthrough into the FLX1 
mRNA as a consequence of Nab3 depletion using an anchors away approach (aqua dots 
with labels, Figure 22; [390]). A number of protein coding genes also showed increased 
RNAPII occupancy such as IMD2, which has previously been shown to have increased 
mRNA production in Ssu72 mutant cells [350]. YDR042c, a protein coding gene of 
unknown function, was also increased in Ssu72-L84F cells. YDR042c was initially 
identified as a protein coding gene that was expressed as a consequence of the ssu72-ts69 
mutation [391]. The sequence changes that occur in ssu72-ts69 have not been determined, 
but it was found to have readthrough transcription at a number of snoRNAs similar to 
Ssu72-L84F. Differential RNAPII occupancy was also observed at genes that have not 
previously been shown to be regulated by Ssu72 such as Yvh1, which encodes a dual 





Figure 22: ChIP-exo differential RNAPII occupancy. Volcano plot illustrating Ssu72-
L84F differential RNAPII occupancy at genes. Differential occupancy was calculated 
using the edgeR package but used ChIP-exo data instead of using RNA-seq data for the 
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Through more in-depth characterization of the target genes altered by the Ssu72-L84F, 
there is potential to obtain unique insights into the precise mechanisms that underlie the 
requirement for Ssu72 in RNAPII transcription termination. However, these in-depth 
characterization experiments are outside the scope of this current work. 
Global average RNAPII occupancy was plotted at sn/snoRNAs and mRNA genes 
in WT and Ssu72-L84F cells from ChIP-exo data (n=3 for each genotype). The plots for 
the snRNA genes were respective to the transcription start site (TSS) and termination end 
site (TES) and showed similar findings as previously shown single gene examples 
(Compare Figure 23 to Figure 21). The average RNAPII profile in the Ssu72-L84F strain 
had an extended peak downstream of the TES, and this trend continued ~600 nucleotides 
downstream of the TES. These data suggest that RNAPII transcription readthrough at 
sn/snoRNA terminators occurs at many of the 73 target genes in this class (Figure 23). 
However, for protein coding genes, more unique insights can be gleaned from the 
average gene analysis than are obvious from single gene analysis. At protein coding 
genes, RNAPII occupancy at the TES shows increased overall occupancy that extends 
~100 nucleotides downstream but then returns to WT levels of RNAPII occupancy by 
~300 nucleotides (Figure 24B). These data suggest that RNAPII termination at protein 
coding genes may be less efficient in Ssu72-L84F cells than WT leading to accumulation 
of RNAPII at termination sites (Figure 24B). Similar average RNAPII profiles were 
generated but aligned to the TSS rather than the TES.  
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Figure 23: SNR Global ChIP-exo analysis using NGS.plot program. Graphs are centered 
around transcription end sites and transcription start sites of each gene. Read counts are 
averaged across genes in the annotation list and plotted. (A) TES of snRNA genes how a 
clear shift and increase of RNAPII localization. (B) TES of protein coding genes also 




Figure 24: Protein coding Global ChIP-exo analysis using NGS.plot program. non-
overlapping protein coding genes were analyzed. Graphs are centered around 
transcription end sites and transcription start sites of each gene. Read counts are averaged 
across genes in the annotation list and plotted. (A) TSS of snRNA genes show a shift and 
increase of RNAPII downstream of the TSS. (B) TSS of protein coding genes show a 
more interesting picture. Here there is a drop in RNAPII localization during early 
elongation and then an increase downstream of TSS site. This gives evidence that Ssu72 




While increased levels of RNAPII were still obvious towards the 3’ end of RNAPII target 
genes, overall occupancy of RNAPII did not seem to be significantly altered at the TSS 
for either the snRNA genes or the protein coding genes (Figure 23A compared to 22A). 
Interestingly, protein coding genes did show significantly decreased RNAPII occupancy 
in the Ssu72-L84F mutant during early transcription elongation which recovers in late 
elongation as RNAPII nears the 3’ end (Figure 24). 
Early RNAPII elongation is associated with high levels of serine 5 
phosphorylated RNAPII CTD [180, 393]. Nrd1 is one of the few proteins with a CTD 
interacting domain that strongly favors a serine 5 phosphorylated CTD during early 
elongation although serine 5 phosphorylation is also required for capping enzyme 
recruitment. I hypothesize that the Ssu72-L84F mutant is disrupting either the recruitment 
or stable association of the Nrd1 subunit of the NNS complex. This change in Nrd1-
RNAPII interaction likely occurs as a consequence of the hyperactive phosphatase 
activity which leads to overall decreases in serine 5 phosphorylation in Ssu72-L84F cells 
(Figure 17). When comparing the global Nrd1 localization ChIP-exo data in WT cells to 
the Ssu72-L84F ChIP-exo data the peak of Nrd1 occupancy overlaps the region where 
RNAPII occupancy is reduced in the Ssu72-L84F mutant. I conclude that during normal 
elongation RNAPII progression is slowed by various molecular events, such as Nrd1 
binding and RNAPII navigation around well positioned histones, thereby increasing the 
relative occupancy of RNAPII during early elongation. However, if Nrd1 binding is 
reduced as a consequence of hyperactive removal of serine 5 phosphorylation from the 
RNAPII CTD, relative RNAPII occupancy is decreased. These data provide evidence that 
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Nrd1 may participate in an early elongating checkpoint by slowing RNAPII perhaps to 
facilitate a mRNA 5’ end capping checkpoint. 
 
Ssu72-L84F Mass Spectrometry Analysis Reveals Sub-Complex Details of the CPF  
Among the many pathways involved in transcription is the polyadenylation 
dependent transcription termination for which requires CPF and CF1A/B for termination 
and processing of mRNA [112, 117, 118, 237, 256-260]. The exact mechanism by which 
these complexes interact within and between each protein/RNA complex is still unknown 
and elusive. One observation is that there exist subcomplexes within the CPF complex as 
first described by the Greenblatt group and recently confirmed using non-covalent 
electrospray ionization mass spectrometry by the Passmore/Robinson group [256, 284]. 
The Passmore group was able to identify a subunit of the CPF complex, Syc1, which is 
not part of to the entire complex but only a part of the APT [282]. They found that 
presence of the Syc1 protein promoted SNR gene expression compared to the whole of 
the CPF complex that normally targets mRNA genes at the 3’ end.   
In this study, I focused on a Saccharomyces cerevisiae protein complex CPF. I 
used the phosphatase mutant Ssu72-L84F that has increased phosphatase activity which 
results in global readthrough of SNR genes and results in differential protein-protein 
interactions with different members of the CPF complex, specifically with Swd2, Glc7 
and Ref2 of the APT subcomplex. To study the differential PPIs during termination as a 
result of the Ssu72-L84F variant, I optimized a coupled affinity purification XL-MS 
method to identify if there are any differences in the architecture structure of the CPF and 
CF1A complexes. Although these complexes are not the most abundant in the cell, there 
are many members and interacting partners. In addition, I also performed XL-MS on 
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RNAPII as it is an abundant and tight complex in the cell that has numerous well 
documented protein protein interactions (PPI) within and outside of the complex. Of note, 
since there are a number of existing high-resolution crystal structures of the RNAPII 
complex, I can make comparisons between the existing structural data and my 
crosslinking data as a validation approach. 
 
1. Ssu72-L84F Mutation Leads to Change in Protein-Protein Interaction 
Network   
 In order to look at how the Ssu72-L84F mutation might affect the protein-protein 
interaction network, I used affinity purification mass spectrometry. I put a FLAG tag on 
Pta1, which is thought to be a scaffold protein in the CPF complex and more specifically 
in the APT subcomplex, which stands for Associates with PTA1. This protein is best 
suited for this AP-MS study because crystal structures for Ssu72 and Pta1 are available, 
and the activity of Ssu72 is increased when Pta1 is present in vitro. After AP-MS, the 
samples were subjected to SDS-PAGE and silver stain to make sure my purifications are 
successful and clean of any visible contaminants such as human keratins (Figure 25). 
This figure shows one of the biological replicates for a WT strain and a Ssu72-L84F 
strain. The purifications were abundant and free of contaminants which can be analyzed 
more clearly in elution 3. I performed four successful purifications for each strain which 
were digested and then detected on a Q-Exactive H-FX mass spectrometer. The spectra 
detected on the Q-Exactive H-FX were analyzed on the Proteome Discoverer software 
(Thermo) to match the spectra to the proteins the daughter ions belonged to.  
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Figure 25: Affinity purification of termination complex subunits. Silver-stain of eluted 
proteins interacting with bait protein. Pta1 is FLAG tagged in WT and Ssu72-L84F 
strain, stain shows several subunits of the CPF complex. Elution of interaction proteins  
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SAINT analysis was performed on three biological replicate purifications in order 
to identify the probability that the proteins detected were real interactions and not non-
specific binding to the bait. The results for the all of the identified proteins were plotted 
by SAINT probability and fold change (Figure 26). Fold change B from the figure is 
calculated by comparing the total peptide spectral matches to the three mock purifications 
with the highest number of detected spectral matches. All of the CPF complex members 
had a SAINT probability of one which means that the proteins identified have the highest 
possible probability that they are indeed interacting partners. In addition there were many 
proteins involved in the transcription process that also co-purified of Pta1. All of the CPF 
complex proteins have a high ratio of sample to mock fold change values providing even 
more evidence that they are real interactions which is expected for proteins that are in 
complex with each other. Most of the proteins with the highest fold-change scores were 
also CPF complex members meaning that my purifications were relatively clean and that 
there are probably not too many proteins that interact with Pta1 as strongly as the 
members of the CPF complex. 
 In order to see if there is a difference in the protein protein interaction network 
due to the Ssu72-L84F mutation, I plotted a PPI map with color coded strings to represent 
a range of the SAINT probabilities and circles to represent the interacting proteins 
(Figure 27). In this network I focused on four different groups of proteins whose 
interactions I hypothesized could be affected by the Ssu72 mutation; CPF, CF1A, 
RNAPII, and NNS. The CPF group could not be compared with SAINT analysis due to 
the fact that all of the proteins had interaction scores of 1 and did not change with the 
mutation. This suggests that the Ssu72 L84F mutation does not cause major changes in 
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the association of Ssu72 with APT/CPF. RNAPII displayed significant changes in 
interactions due to the mutation in Ssu72. The Ssu72-L84F mutation increased the 
number of RNAPII subunits that interacted with Pta1, specifically Rpb1, Rpb3, Rpb9 and 
Rpb11, while it increased the probability score that Rpb2 had previously from 0.74-0.15 
to >0.95,this suggests that the mutation is causing Pta1 to interact more with RNAPII.  
This is consistent with the ChIP-exo findings in Figure 24 that show that RNAPII levels 
increase at the transcription end site (TES) which is the location at which the CPF 
complex should also be enriched. The CF1A complex and associated proteins did not 
show as much change as RNAPII. NNS complex proteins also displayed no significant 
change in the SAINT probability scores. 
 
2. Ssu72-L84F Mutation Differential PPI Analysis Reveals Different 
Mechanistic Roles in CPF complex    
Because the CPF was very abundant in the AP-MS study, all of the proteins in the 
complex had the highest SAINT probability score of 1. This makes it hard to see if there 
are any differences in the interactions within the complex. Therefore, I employed a 
method using the same SAINT analysis algorithm and altering it to analyze the 
differential PPI between two samples. SAINT analysis is usually performed by 
comparing a sample to a mock purification which gives the probability that an interaction 
is a true interaction. Instead, I used SAINT to compare two different samples to each 
other setting the WT as though it were a mock purification (Figure 28).   
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Figure 26: SAINT analysis of WT and Ssu72-L84F. (A) Fold Change of peptide spectral 
matches from WT plotted against SAINT probability (of a true interaction) (B) Saint 
probability vs. fold change for Ssu72-L84F 
  
CPF complex Non-CPF proteins
A B
CPF complex Non-CPF proteins
Ssu72-L84F Visualization: SAINT vs FC-B (N=3)WT Visualization: SAINT vs FC-B (N=3)
Log2 (FC-B score) Log2 (FC-B score)
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Figure 27: Purification of RNAPII termination complex. Pta1 is tagged with 3XFLAG 
sequence and purified using FLAG antibodies. Protein-protein interaction analysis 
obtained from SAINT analysis of LC-MS/MS raw data of purified termination factor 



































Using this method, we calculated a statistical SAINT value for the probability that there 
is a difference between specific protein interactions with the bait in the Ssu72-L84F 
mutant compared to the WT. This analysis highlighted a set of four proteins, Glc7, Ref2, 
Swd2 and Ubx1, which had a high probability that they were differentially interacting 
with Pta1 relative to WT. This is interesting because all of these proteins are part of the 
APT complex except for Ubx1, a ubiquitin binding protein which is known to positively 
regulate Glc7 activity[394].In addition, these three CPF proteins have been found in a 
previous study to fragment together in ESI-mass spectrometry from the CPF complex 
relative to the other subunits[284]. This provides evidence that there may be another 
subcomplex within the APT subcomplex and that the Ssu72-L84F mutation is regulating 
the formation of this subcomplex. It is also possible that this subcomplex is regulating 
NNS termination in an independent mechanism from the CPF termination mechanism at 
the 3’ end of mRNA genes. Other CPF complex proteins also had a relatively high 
probability of differential PPI, but the SAINT probability scores for these proteins were 
not high enough to confidently say that they were true differential interactions as a result 
of the Ssu72-L84F mutant. As expected, the Pta1 protein had a very low probability score 
since it cannot differentially interact with itself as it is the bait protein. Interestingly other 
transcription proteins had high probability scores such as NNS complex proteins 
Nrd1/Nab3/Sen1, RNAPII complex protein Rpb11and 3’ end processing protein Xrn2. 
 
3. Development of Protein Complex Cross-Linking of in Vivo Proteins  
In order to better understand how proteins might differentially interact with each 
other at the residue level, I sought to develop a method which uses cross-linking mass 
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spectrometry with my affinity-purification mass spectrometry studies. This method 
utilizes a CID cleavable crosslinker called DSSO that can be identified in the mass 
spectrometer and in a package in Proteome discoverer called XlinkX. During the 
development of this method, 5 and 4 biological replicates were performed for Ssu72-
L84F and WT cells. Of those that yielded cross-linking results, there were 35 unique 
cross-links per technical replicate (3 per biological replicate) (Figure 29). I was able to 
uncover several unique intra and inter crosslinks but was not able to recover intralinks 
from all of the different CPF complex proteins. In order to verify my experiment, I 
compared some of my crosslinks to a cryo-EM structure of Cft1 and Pfs2 (Figure 30). 
The distance between the nitrogen atom of the lysine side chain residue was measured for 
two intralinks and one interlink. One of the two lysine residues Cft1 lysine 211 was not 
included in my map since it had lower probability of being a true crosslink according to 
xlinkx software. This result is interesting considering that the distance, 15.2 Å, between 
nitrogen atoms was longer than the other two crosslinks and longer than the DSSO 
molecule. The other two crosslinks’ nitrogen atoms were closer to each other and the 
distance between nitrogen atoms was 8.7 Å for the intralink and 11.7 Å for the interlink. 
This gives me confidence that my crosslinks more than likely are true crosslinks.  
In addition to the CPF cross-linking experiments, I also carried out cross-linking 
experiments with the CF1A complex and RNAPII (Figure 31). The CF1A complex had 
very few cross-links while the RNAPII complex had several hundred unique cross-links. 
It is likely that larger protein complexes that are more abundant can yield better cross-
linking results.  
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Figure 28: Differential protein-protein analysis in the  Ssu72-L84F mutation using 
SAINT analysis algorithm. WT data was used as a mock control to statistically 
distinguish two different groups of data and identify real differential interactions between 
































































Figure 29: DSSO XL-MS analysis of CPF complexes by MS2-MS3 CID on an 
Orbitrap Fusion Lumos. (A) Ssu72-L84F CPF complex mapping intra-links and inter-
links (B) WT CPF complex mapping intra-links and inter-links.
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Figure 30: DSSO XL-MS verification with cryo-EM structure of Cft1 and Pfs2 of CPF 
complex. Detected crosslinks are verified by measuring predicted distances from the 
nitrogen atoms of the lysine side chains. Cft1 is in red and Pfs2 is in purple. DSSO spacer 
length is 10.1 Å. Original structure was determined at 3.5 Å resolution (PDB 
ID:6EOJ)[284] 
  












Figure 31: DSSO XL-MS analysis of CF1A and RNAPII complexes by MS2-MS3 CID 
on an Orbitrap Fusion Lumos. (A) WT CF1A complex mapping intra-links and inter-




This work explores the role of RNAPII phosphatases Rtr1 and Ssu72 in the 
regulation of transcription termination and elongation. My work has determined that both 
phosphatases have distinct roles in regulating transcription termination pathways, 
specifically NNS-dependent termination. In order to effectively interrogate the 
complicated mechanism of transcriptional regulation by dynamic RNAPII 
phosphorylation patterns, several cutting-edge methods were adopted and optimized, 
such as RNA-Seq, ChIP-exo, AP-MS and XL-MS. Additionally, I was able to use and 
help develop new methods and approaches in the Mosley lab such as DisCo - a 
differential PPI approach, and affinity purification-based crosslinking that was 
instrumental in my studies. Utilization of this multi-omics approach has been critical to 
the success of my dissertation work. 
 
Rtr1 Regulates Transcription Termination 
In the recent past there was a debate as to whether or not Rtr1 was indeed a CTD 
serine 5 phosphatase. Since Rtr1 does not have the conventional catalytic site found in 
other classes of protein phosphatases, some questioned whether Rtr1 was a phosphatase. 
While work from the Mosley lab and others provided strong evidence for its phosphatase 
activity towards the CTD and other in vitro phosphatase assay substrates, the importance 
of its role in vivo remained ambiguous as a consequence of its potential functional 
redundancy with Ssu72 and its low activity levels in in vitro experiments [203, 205, 206, 
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302, 359, 395, 396]. My work indicates that Rtr1, through its phosphatase activity, has an 
important role in the regulation of poly-A independent transcription termination.   
DisCo analysis, a novel AP-MS method developed in the Mosley Lab, was 
applied to obtain a detailed snapshot of perturbations in protein-protein interactions 
during transcription elongation and termination as a result of deleting RTR1. The AP-MS 
SAINT analysis for each of the above purifications revealed that RTR1 deletion does 
have an effect on the Nrd1-TAP and Pcf11-FLAG PPIs (Figure 7C). While Nrd1-TAP 
rtr1Δ cells had a low SAINT probability score for interaction with Rpb1, the Pcf11-TAP 
rtr1Δ cells lost moderate SAINT probability score for Rpb1 and Rpb2 interactions. At 
first glance, the loss of interactions with Pcf11 and gain of interactions with Nrd1 appear 
to be opposing effects, but it is difficult to interpret exactly how these interaction changes 
would impact each different termination mechanism. This is especially true since Nrd1 
prefers a serine 5 phosphorylated CTD, and Pcf11 prefers a serine 2 phosphorylated 
CTD. But, both the NNS and CFIa complexes have other subunits which interact with 
RNA. 
Compared to the individual SAINT analysis on the different AP-MS studies, the 
DisCo study showed that deleting Rtr1 has a global effect. The correlations that different 
proteins had with each other in the WT decreased and/or disappeared when Rtr1 was 
removed (Figure 7A/B). It appears that Rtr1 is required to maintain stable interactions 
which can survive purification of different termination complexes. It is important to note 
that the DisCo results are not due to the overall decrease between the different complexes 
of the entire analysis since each correlation value is calculated using data from two bait 
proteins and the SAINT values from each biological replicate relative to these proteins 
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(Nrd1 and Pcf11). The decrease of inter-complex interactions suggests that higher order 
interactions between these complexes are important for proper transcription. Decreased 
and/or destabilized interactions between complexes could decrease the efficiency of 
termination. Overall this could reduce diversity in the number of distinct transcripts that 
are produced during transcription.  
How does Rtr1 link the different complexes together? The answer to this question 
may be found within my genomic analysis of RTR1 knockout cells. Studying RNA levels 
is essential to investigate transcription as a surrogate measure of the average activity of 
the transcription machinery. For this work, total RNA-seq analysis was performed which 
includes ncRNA (Figure 10). Deletion of RTR1 showed an overall decrease in total RNA 
with a greater impact on ncRNA relative to mRNA. This decrease in ncRNA gives the 
first piece of evidence that RTR1 deletion may have more of an effect on the NNS 
dependent termination which is known to regulate ncRNA [12, 148, 153, 165, 376]. The 
YKL151C Northern blots provide an example of a ncRNA YKL151 AST having reduced 
expression, and possibly as a result, an increase in YKL151 mRNA expression (Figure 
15). The single AP-MS SAINT analysis data for Nrd1 in RTR1 knockout cells supports 
these findings in that Nrd1 has increased interaction with Rpb1 relative to WT. These 
data suggest that NNS activity is increased, thus there was a decrease in the number of 
stable ncRNA detected. This leads to the following hypothesis: deletion of RTR1 
increases S5P levels in the cell which would increase the binding sites for Nrd1 to bind to 
RNAPII, specifically Rpb1, and increase the efficiency of NNS transcription termination 
(Figure 32).   
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Figure 32: Model for Rtr1 effect on NNS termination. No Rtr1 phosphatase activity leads 
to increased serine 5 phosphorylated CTD sites. More serine 5 phosphorylated sites lead 
to increased rate of Nrd1 binding to the CTD. Increased binding of Nrd1 to CTD leads to 











Nrd1 and RNAPII occupancy was measured on RNAPII target genes using ChIP-exo 
(Figure 9-11). The ChIP-exo data show that RNAPII and Nrd1 levels are decreased on 
the gene as a result of the RTR1 deletion. It is possible that NNS termination is becoming 
more efficient from a mechanistic perspective and not as a consequence of a greater 
number of NNS subunits present with RNAPII, which would mean that less Nrd1 could 
be required at the termination site to induce termination. When analyzing the changes 
observed in rtr1Δ cells, one should note that the impact of NNS-dependent termination 
on the transcriptome is regulated by at least two major mechanisms. The first is that the 
NRD1 expression levels are autoregulated by the Nrd1 protein itself. Thus, an increase in 
Nrd1 termination efficiency would lead to a corresponding decrease in NRD1 mRNA and 
possibly protein levels. Secondly, increased Nrd1 termination could be causing a reduced 
number of stable ncRNA in the cell which would be mediated through the activity of 
Rrp6 in the nuclear RNA exosome. It is possible that RNAPII could be transcribing the 
ncRNA properly, but if Rrp6 is acting more efficiently, it could be degrading the RNA 
before it is measured with my RNA-Seq experiments. For this reason, an RRP6 knockout 
mutant and an RTR1 RRP6 double knockout mutant were used to assess whether 
degradation of the ncRNA alone could explain the results. Two examples of well-studied 
protein coding genes that are known to be regulated by transcription of ncRNA through 
transcription interference are shown. Analysis of both IMD2 and YKL151C do not 
support the hypothesis that the effect caused by deleting RTR1 leads the RNA exosome to 
be defective and degrade ncRNA. As assessed by RNA-Seq and Northern blot analysis, 
the rrp6Δ cells differ from the rtr1Δ/rrp6Δ. If the effect of RTR1 deletion was dependent 
on Rrp6, then the double mutant should act identically to cells with only rrp6Δ. However, 
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when looking at global AST transcripts, the double mutant did resemble the single RRP6 
knockout mutant. This would mean that most AST transcripts do depend on Rrp6 activity 
and that Rtr1 does have an influence on the RNA exosome on most genes. Collectively 
these results lead me to conclude that Rtr1 may play a role in attenuating NNS dependent 
termination. However, it also plays a role in positively regulating the stability of ncRNA 
via the RNA exosome. This is consistent with previous work in the Mosley lab that 
showed that Rrp6 acts with the NNS complex to promote transcription termination as 
well as processing and degradation[248].   
 
Ssu72-L84F Mutant Elucidates Possible Roles in Transcription Termination 
Mechanism That Are Independent From Rtr1s Role 
Ssu72 was the first S5P phosphatase discovered, and, because of its interactions 
with TFIIB, has commanded significant attention in the field. As an essential member of 
the CPF, it is likely involved in poly-A dependent termination and possibly also in 
initiation through its interaction with TFIIB. In addition, as a S5P phosphatase, it should 
also theoretically be involved in early elongation when S5P is most abundant [180, 393]. 
The role of Rtr1 and Ssu72 phosphatases in RNAPII transcription and how they differ 
and are similar have not been fully defined. Investigation of these areas is important to 
determine whether Rtr1 and Ssu72 are redundant and/or specific. There is evidence that 
Ssu72 prefers a serine 5 phosphorylated CTD where, a proline 6 is in a trans 
conformation [303]. However, other conformational differences and combinations of 
phosphorylated residues, in addition to proline 6 isomerization, could exist that each of 
the two phosphatases prefer. 
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Ssu72 is an essential gene, as thus most studies have focused on an Ssu72 mutant. 
All of these mutants have generally caused a loss of function in Ssu72 that led to defects 
in transcription. One such study found a set of transcripts, that were affected by a Ssu72-
R129A mutant, which they called the SRTs [13]. In this study I used a new mutant, 
Ssu72-L84F, which arose spontaneously in a genetic screen that appeared to over-ride 
termination [350]). As the other Ssu72 mutants were well studied and could already be 
compared to my Rtr1 data, I wanted to look at the new Ssu72-L84F mutant to have an 
additional unique set of Ssu72 mutant data to compare to Rtr1 as well as to better 
understand what effect the mutation of Ssu72 had on Ssu72s activity and in the cell. 
In three separate experiments, it was confirmed that Ssu72-L84F has increased 
phosphatase activity, which is the first Ssu72 mutant to have such a phenotype (Figure 
16). Interestingly it appears as though other mutations in the same location would have 
even greater effects, but it is uncertain whether a yeast cell with this mutation would be 
viable or even have the same TOV phenotype. In addition, all of the phosphorylation 
levels at the serine residues in the CTD appeared to be decreased although it is not clear 
if they are directly dephosphorylated by Ssu72 or by a mechanism dependent on Ssu72. 
Since Ssu72 is known to also dephosphorylate S7P and is also a member of the 
phosphatase module in the CPF, S2/5/7P dephosphorylation could be a combination of 
both direct dephosphorylation of the serine residues and stimulation of their 
dephosphorylation through downstream mechanisms, such as Fcp1 activity. 
Total RNA-seq analysis of Ssu72-L84F cells was performed to compare the 
differential expression analysis of the two phosphatases directly without experimental 
bias. Again, in the Ssu72-L84F data it was the ncRNA that were affected, but this time 
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the ncRNA were all increased very distinctly relative to rtr1Δ cells that had a decrease in 
the ncRNA expression levels. Curiously, it appears that different classes of ncRNA were 
affected more by Rtr1 (ASTs) and others were affected more by Ssu72 mutations (CUTS, 
SRTs, and SNRs) while both seemed to affect NUTs in a similar way. Northern blot 
analysis was also performed to confirm genuine read-through and the presence of their 
full-length transcripts of SNR genes snR33 and snr82. Curiously the levels of RNA 
expression of the elongated transcripts relative to the correct snoRNA as measured by 
RNA-seq and Northern blot were not in agreement. Northern blot data displayed a much 
smaller elongated transcript blot relative to the short snoRNA transcripts. Whereas the 
RNA-seq data displayed similar levels of elongated vs snoRNA expression levels. It is 
possible that this difference is result of the limitations of RNA-seq when measuring very 
high quantities of RNA as they could have a saturation maximum or problems with 
library amplification.   
Analysis of RNA expression in an rrp6Δ mutant showed that the Ssu72-L84F 
mutation effect was not an effect of a defective RNA exosome since the rrp6Δ lane 
showed a different shorter RNA transcript product. The difference in RNA products show 
further evidence that the Ssu72-L84F mutation has a termination read-through effect and 
not a degradation defect phenotype. The read-through transcript size aligns with the 
length of DNA from the SNRs TSS to the downstream genes TES which means that the 
Ssu72-L84F mutation is affecting ncRNA termination but probably not poly-A dependent 
termination. It is interesting to note that when a double rtr1Δ Ssu72-L84F mutant was 
used, Northern blot analysis displayed the characteristic of Ssu72-L84F in that it there 
was a very similar read-through effect (data not shown). This is evidence that the L84F 
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mutation on Ssu72 could be inducing a loss of its specificity and targeting S5P that would 
have normally been dephosphorylated. This hypothesis makes sense since the L84F 
mutation is localized near the de-phosphorylation active site and loss of specificity would 
allow Ssu72 to dephosphorylate indiscriminately at a higher rate.  
ChIP-exo results of an Rpb3-FLAG tagged strain for WT and Ssu72-L84F for snR82 and 
snR33 displayed similar results as the RNA-seq analysis when comparing the mutant to 
the WT, although the difference between the two strains in the RNA-seq analysis was 
much more pronounced. The global average reads from ChIP-exo data for RNAPII 
showed more interesting results in both ncRNA and mRNA genes. The differences 
between the average RNAPII occupancy for Ssu72-L84F compared to WT at snRNA 
genes was quite pronounced at both the TES and the TSS. At the TSS there is not much 
difference in RNAPII occupancy which gives evidence to the idea that the mutant does 
not affect initiation of transcription. It also appears as though elongation is not affected in 
the SNR genes. Whereas the SNR genes have a large shift downstream of the TES 
relative to WT which is consistent with the idea that the Ssu72-L84F mutant is causing 
termination over-ride at the SNR genes. In addition, there was an accumulation of 
RNAPII at the TES in the SNR genes, and it appears as though RNAPII is stalling at this 
region, perhaps trying to initiate termination but for some reason being unable. This same 
accumulation of RNAPII at the TES is also apparent in the protein coding genes. The 
shift downstream of the TES is not present which could mean that the Ssu72-L84F 
mutation is causing an accumulation of RNAPII at the TES of poly-A dependent genes 
but is still terminating at the appropriate location indicating that it might be temporally 
delayed. Surprisingly, there was also a decrease in RNAPII occupancy during early 
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elongation of protein coding genes, an effect that was not seen in the SNR genes. My 
model postulates that the Ssu72-L84F mutation is having an effect on NNS termination 
which occurs in a similar area as peak Nrd1-TAP occupancy, which can be seen when 
compared to the average Rpb3-FLAG occupancy ChIP-exo data (Figure 33). As 
mentioned, the localization of Nrd1 is at the same region where RNAPII localization is 
reduced in the protein coding genes for the Ssu72-L84F mutant. This result leads to the 
model that Ssu72-L84F mutation is increasing phosphatase activity thus reducing the 
sites of S5P that Nrd1 can bind to and inhibit NNS dependent termination (Figure 34). 
Therefore, I believe that the Ssu72-L84F mutation is affecting NNS termination of 
ncRNA, but the NNS complex might also be involved in early elongation in protein 
coding genes as a possible checkpoint that RNAPII has to go through before it continues 
to elongate the nascent RNA. 
The Ssu72-L84F mutant had a very drastic effect on RNAPII localization, but the 
effects of rtr1Δ on RNAPII were generally subtler. It appears as though Ssu72 
phosphatase is necessary to stimulate NNS termination, but Rtr1 actually attenuates NNS 
termination. Although Ssu72 has been shown to be involved in termination previously, 
this is a novel role for Rtr1. It is interesting that both Ssu72 and Rtr1 seemingly target the 
same serine residue on the CTD, but they each appear to have opposite effects on 
transcription. One could say that the mutation confers opposite phenotypes on the 
phosphatases themselves. However, other mutations in Ssu72 that have decreased 
phosphatase activity also confer a read-through phenotype [13]. This gives further 
evidence that these phosphatases have a separate and unique role in transcription and that 
they are probably targeting structurally unique RNAPII S5P sites.   
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Figure 33: Global ChIP-exo analysis using NGS.plot program. Non-overlapping protein 
coding genes were analyzed. Graph is centered around transcription start sites of each 
gene. Read counts are averaged across genes in the annotation list and plotted. TSS of 
protein coding genes show a more interesting picture. Nrd1-TAP ChIP-exo data is 
overlaid to the Ssu72-L84F data. The drop in RNAPII localization during early 
elongation aligns with spike of localization of Nrd1. This further supports my evidence  




Figure 34: Model for Ssu72-L84F effect on NNS termination. Increased phosphatase 
activity of Ssu72 leads to fewer serine 5 phosphorylated CTD sites. Less serine 5 
phosphorylated sites lead to decreased rate of Nrd1 binding to CTD. Decreased binding 
of NRd1 to CTD leads to a less efficient NNS induced RNAPII termination and less Nrd1 





This hypothesis could be further corroborated by studies with a hyperactive Rtr1 if such a 
scenario could be engineered.  
 
Ssu72-L84F Reveals Independent Functionality in Subcomplex Within CPF  
Our Ssu72-L84F studies revealed possible independent functionalities of a 
subcomplex within the CPF complex. It is possible that Ssu72s main function in 
transcription is further downstream of the TSS relative to Rtr1. The mutation may have 
caused a decrease in Ssu72 dephosphorylation site specificity causing the termination 
over-ride phenotype. However, differential PPI proteomics data showed a distinct 
separation of a group of different subunits within the CPF complex due to the Ssu72-
L84F mutation. Furthermore, this same group of proteins has recently been described as 
an independent group structurally separate from the rest of the CPF in a different 
experiment. These data may suggest the functionality of this group using the Ssu72-L84F 
mutant. It is possible that this subcomplex of proteins is acting separately from the rest of 
the complex, which is supported by recent work showing that when the Syc1 protein is 
present there exists a distinct subcomplex APT. APT includes Ssu72 as well as the 
proteins that have differential PPI in the Ssu72-L84F strains. However, my differential 
PPI data does not include all of the APT complex members, on at least not with a high 
SAINT probability. It is possible that that a smaller subcomplex exists within the APT 
complex that has a distinct function within the cell that is being affected by the Ssu72-
L84F mutation. For this reason, the architecture of the protein complexes in the Ssu72-
L84F mutation were investigated through the development of the cross-linking mass 
spectrometry methods. The cross-linking method shows promise and with further 
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development this method should become a powerful tool for analyzing the effects that the 
Ssu72-L84F mutation as well as other mutations have on their respective complexes.  
 
Conclusions and Future Directions  
Through this work I have been able to distinguish the unique roles that the Rtr1 
and Ssu72 phosphatase have on transcription termination. However, this work has also 
brought about new questions that would be interesting to answer. My overall findings 
have once again displayed that biology is extremely complicated system and that even the 
most seemingly simple mechanisms are riddled with intricate details is connected to 
several aspects of biology.   
Rtr1 was recently (2009) a protein of unknown function. Even more recently its 
function was still debated. However, work in the Mosley lab and others have uncovered 
more information about the protein and its function. In this work my data provides 
evidence the Rtr1 appears to be acting as a sort of gateway that enables elongation to 
continue and promotes protein interactions between transcription machinery. Most Ssu72 
mutants, loss of phosphatase activity mutants or gain of phosphatase activity mutants, 
have reduced termination and increased readthrough which is the opposite of the rtr1Δ 
strain even though both are S5P phosphatases. This result then introduces the question 
that if removing Rtr1 has the same effect on serine 5 of the CTD as a loss of activity 
Ssu72 mutant phosphatase then why is the phenotype different. Again, the simple action 
of removing the S5P from the CTD is becoming increasingly intricate and my results 
provide evidence that this is likely the case for the other phosphatases and kinases as well 
as the other transcription machinery. 
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It would be interesting to verify whether or not the rtr1Δ phenotype is a direct 
result of the loss of S5P. If it is then it would be worthwhile to investigate the structural 
differences between an Rtr1 S5P CTD target and an Ssu72 S5P target. This could 
possibly be done by using structurally unique synthetic heptad peptides of various 
repeats, phosphorylation patterns, and other structurally unique peptides in a phosphatase 
activity assay. If the rtr1Δ phenotype is a result of something other than the loss of S5P 
then it is possible that Rtr1 may be acting on other proteins involved in transcription and 
further studies can be done to look at differential phospho-proteomics as a result of the 
rtr1Δ to identify possible targets of Rtr1. In addition, I have preliminary Northern blot 
data that shows that an rtr1Δ/Ssu72-L84F double mutant results in RNA products similar 
to those found in the Ssu72-L84F mutant so it appears that the Ssu72 mutations 
overwhelms the effects of RTR1 deletion. However, it is still unclear if the double mutant 
reduces the interactions between the transcription machinery in the same way as an rtr1Δ 
strain. Thus, in future studies it would be a good idea to implement a DisCo study in the 
double mutant to see if the interactions between the different transcription machinery are 
restored.  
My studies with Ssu72 led to surprising results in its effect in early mRNA 
elongation and within the complex that it is a part of CPF. Not only did the Ssu72-L84F 
mutation confer a definitive read-through effect in ncRNA genes but they also led to a 
decrease in occupancy at the early elongation stage and an accumulation in effects in 
mRNA genes. The differential PPI analysis identified a subset of the APT module 
proteins are interacting with Pta1 more often than other CPF members. The finding that 
Ssu72 is not only acting during at termination with its complex but within a sub-complex 
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of the module again highlights the number of layers that exist in transcription mechanism 
that is occurring within the cell. It also calls to attention the heterogeneity that protein 
complexes have. Proteins may not always be in just one complex but they may act 
independently or in a completely separate complex. 
In the future I will continue the cross-linking studies to gain further information 
on the interactions that occur in CPF, CF1A, as well as other important protein 
complexes involved in transcription. By doing this I can create a very detailed map of 
how proteins interact with each other going one step further than AP-MS PPI studies that 
cannot distinguish between primary, secondary or n interactions. In addition, I will be 
able to distinguish if there is a change in which regions of the protein where they are 
interacting as a result of the Ssu72-L84F or other mutations. I will also perform a whole 
proteome experiment using tandem mass tags to accurately quantify the amount of 
different proteins in the cell to find out if there is a change in the expression of different 
proteins. In order to verify that there is a sub complex within the APT module of the CPF 
in the Ssu72-L84F mutant I will do an anion exchange separation experiment with the 
CPF complex to identify if a different sub-complex exists on its own and travels together 
in the column. Since RNAPII is accumulated at the 3’ end of mRNA genes in the Ssu72-
L84F mutant relative to WT it is possible that cleavage and polyadenylation function is 
altered. To test this, I will perform a cleavage and polyadenylation assay using an RNA 
substrate with purified CPF and CF1A complex from an Ssu72-L84F mutant strain as 
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numerical chromosomal abnormalities as well as cell death and the ability of a certain 





Genetics: Infectious Diseases, Research Internship,   (10/2011-2/2012) 
LABioMed, Torrance, CA    
Duties included: Culture and maintain different bacterial cell lines of Staphylococcus 
aureus. Perform kill curve, cytochrome c, 96 well plate, peptide susceptibility, and 
population assays to analyze the effects of different gene deletions in the model 
organism’s growth rate, death rate, response to different human peptides, and population 
densities. 
 
Genome Evolution Research Assistant, UCI, Irvine, CA  (6/2010-10/2010) 
Duties included: Build up and maintain Drosophila melanogaster stocks, prepare and 
conduct crosses of strains of drosophila containing different transposable elements and 
analyze the effects of different elements that have been inserted, analyze sequences of 
elements and predict possible effects elements have on altering genes near the insertion 
site, discuss and report findings and progress of experiment. 
 
Teaching Experience 
G848 Teachers Assistant       (2/2018-5/2018) 
Bioinformatics, Genomics, and Proteomics (Graduate Student Course) 
 
Instructor, Bio 103L,       (1/2013-5/2014) 
California State University Dominguez Hills 
 
Presentations/Publications 
J. Victorino, M. Fox, W. Smith-Kinnaman, S. Peck, K. Hughes, A. Boyd, M. Zimmerly, 
R. Chan, G. Hunter, Y. Liu, AM. Mosley (2020). RNA Polymerase II CTD phosphatase 
Rtr1 fine-tunes transcription termination. PLOS Genetics 
 
S. Peck, K. Hughes, J. Victorino, and A. Mosley (2019). Writing a Wrong: Coupled 
RNA Polymerase II Transcription and RNA Quality Control. WIREs RNA 
 
T. Kunkle, S. Abdeen, N. Salim, AM. Ray, M. Stevens, A. J. Ambrose, J. Victorino, Y. 
Park, Q. Q. Hoang, E. Chapman, and S. M. Johnson (2018) Hydroxybiphenylamide 
GroEL/ES inhibitors are potent antibacterials against planktonic and biofilm forms of 
Staphylococcus aureus. Journal of Medicinal Chemistry 
 
RB Slee, BR Grimes, R Bansal, J Gore, C Blackburn, L Brown, R Gasaway, JJeong, J 
Victorino, KL March, R Colombo, BS Herbert, and Murray Korc (2013). Selective 
inhibition of pancreatic ductal adenocarcinoma cell growth by the mitotic MPS1 kinase 
inhibitor, NMS-P715. Molecular Cancer Therapeutics  
 
Rustbelt RNA Meeting Poster  (10/2018) 
Columbus, Ohio 
 
IUSM Biochemistry and Molecular Biology Research Day Poster  (10/30/2018) 
Transcriptional Regulation by Chromatin and RNA Polymerase II Poster (10/04/2018) 
(hosted by ASBMB), Snowbird, Utah 
 
Purdue Chromatin and Epigenomics Symposium Poster (06/2018) 
 
Rustbelt RNA Meeting Talk  (10/2017) 
Indianapolis, Indiana 
 
IUSM Biochemistry and Molecular Biology Research Day Talk (09/2017) 
 
IUSM Biochemistry and Molecular Biology Research Day Poster (09/2017) 
(Honorable mention)  
 
Chromatin and Epigenomics Symposium Talk (10/2016) 
 
CSUSH Student Research Day Oral presentation competition (2nd Place)  (01/2013) 
 
Summer Poster Symposium, Hosted by CRL at IUPUI  (07/2013) 
 
Summer Poster Symposium, Hosted by CRL at IUPUI  (07/2012) 
 
Professional Conferences/Courses 
67th American Society of Mass Spectrometry Annual Conference  (06/4/2019) 
 
ASMS LC-MS: Practical Maintenance and Troubleshooting  (06/01/2019) 
 
65th American Society of Mass Spectrometry Annual Conference  (06/04/2017) 
 
Mechanisms of Eukaryotic Transcription,     (08/25/2015) 
Cold Spring Harbor, NY  
 
40th SACNAS, San Antonio, TX      (10/03/2013) 
 
25th Annual CSU Biotechnology Symposium, Anaheim, CA  (01/03/2013) 
 
